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ABSTRACT

During an immune response, T cell activation is mirrored by a dramatic metabolic
shift from oxidative phosphorylation to glycolysis. The upregulation of glycolysis allows
the cell to generate the molecules needed to rapidly proliferate and to synthesize effector
molecules. The resolution of the T cell response is characterized by equally fast death of
most effector T cells. The remaining T cells shift back to oxidative phosphorylation,
allowing the cell to survive as a memory T cell. The upregulation of glycolysis and
proliferation during the effector phase is paralleled by an increased sensitivity to T cell
receptor restimulation-induced cell death (RICD). Whereas cellular metabolism and cell
death are important in the proper function and response of T cells, it is not clear how
metabolism regulates susceptibility to cell death, nor whether T cell proliferation and
contraction are directly connected. The work presented in this dissertation provides a
mechanistic link between T cell proliferation and contraction by demonstrating the
regulation of caspase-3 activity by the metabolic state of T cells.
In effector T cells, the cytokine interleukin (IL)-2 mediates the upregulation of
glycolysis, while IL-15 induces oxidative phosphorylation and a memory-like state. IL-2
is known to sensitize T cells to RICD, while IL-15 reduces RICD and increases survival.
This results from the ability of IL-2 and glycolysis to increase caspase-3 activity, whereas
IL-15 induces the opposite phenotype. Activation of caspase-3 during glycolysis is
mediated through clustering in lipid rafts in the plasma membrane. IL-15 is shown to
inactivate caspase-3 through the posttranslational modification of protein
glutathionylation, which is mediated by ROS generation in the mitochondria as a byproduct of oxidative phosphorylation.
We further observe that glycolysis parallels the reduced activity of the electron
transport chain and oxidative phosphorylation, further increasing caspase-3 activity. This
is mediated by the decreased expression of electron transport chain complexes and an
increase in expression of the negative regulator of complex I, methylation-controlled J
protein (MCJ). IL-15 promotes reduced expression of MCJ by its methylation. Similar to
IL-15-cultured T cells, MCJ-deficient T cells manifest reduced glycolysis, caspase-3
activity, and RICD. Collectively, these findings demonstrate an adaptation that links
metabolism to both cell proliferation and cell death to safeguard that proliferating cells do
not escape regulation that could result in autoimmune disease or lymphomas.
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CHAPTER 1: COMPREHENSIVE LITERATURE REVIEW

1

1.1 The Immune System
The immune system is a network of proteins, cells, and tissues that protects the
host from infections by bacteria, fungi, viruses, and parasites. Defense is achieved
through the ability to recognize non-self from self. To do this, the immune system utilizes
many different cells that are specialized in recognizing and responding to self and nonself molecules. To maintain both speed and breadth of response to infections, the immune
system contains two different branches that evolved at different times, the innate immune
system that is found even in insects, and the adaptive immune system found only in
vertebrates (Yatim and Lakkis, 2015).
1.1.1 Innate immune system
The innate immune system acts to generate a quick protection from pathogens. It
takes the strategy of having a limited number of non-polymorphic receptors that
recognize a limited number of motifs from microorganisms. The co-evolution of these
receptors and their ligands provides high affinity and hence a rapid response (Martin,
2014).
The complement system represents a group of proteins that cleave in a very
precise order to induce inflammation and assist in the attack of microbial pathogens
(Tomar and De, 2014). The proteins of the complement system work in three different
pathways: the classical pathway, the lectin pathway, and the alternative pathway. These
pathways all converge at the activation of the C3 convertase but are initiated by different
means (Walport, 2001). The classical pathway is typically activated by antibodies bound
to the surface of the pathogen. This leads to the binding of the C1 complex, which
activates the C3 convertase (Walport, 2001). The lectin pathway is activated by either the
2

collectins mannose-binding lectin (MBL) or CL-K1, or the ficollins, which bind to
carbohydrates on the surface of the pathogen and activate the MBL-associate serine
proteases (MASPs). The MASPs then activate the C3 convertase (Kjaer et al., 2013). The
alternative pathway is spontaneously activated in the serum through constant hydrolysis
of the complement protein C3 (Roumenina et al., 2011). Upon binding to self surfaces,
the pathway is inactivated by the prevention of C3 convertase formation. When
hydrolyzed C3 binds to a pathogen, more complement proteins are deposited on the
surface of the pathogen, and theC3 convertase becomes activated (Roumenina et al.,
2011). Once the C3 convertase is activated, complement proteins are deposited onto the
pathogen that result in opsonization and phagocytosis, or the formation of a membraneattack complex which forms a pore and kills the pathogen (Walport, 2001).
The cells of the innate immune system are varied and act to attack pathogens as
well as to activate the adaptive immune system. Innate immune cells recognize
components of pathogens called pathogen-associated molecular patterns (PAMPs) via
intracellular and surface receptors known as pattern recognition receptors (PRRs)
(Martin, 2014). Upon recognition, signaling through PRRs lead to the activation of the
innate immune cells and the production of inflammatory cytokines (Martin, 2014).
PAMPs can be a number of different antigens from pathogens, ranging from DNA to
fragments of bacterial flagella. PRRs include Toll-like receptors, NLRP proteins of the
inflammasome, the RNA-sensing RIG-I pathway, and DNA-sensing cGAS/STING
pathway (Cai et al., 2014; Janeway and Medzhitov, 2002; Kell and Gale, 2015; Martin,
2014). The cells that express PRRs include granulocytes (basophils, eosinophils, and
neutrophils), natural killer (NK) cells, dendritic cells (DCs), macrophages, and mast cells
3

(Janeway and Medzhitov, 2002). Macrophages and DCs are able to phagocytose
pathogens, degrade their proteins, and present peptide fragments of them on MHC
molecules to T cells in the adaptive immune system (Janeway and Medzhitov, 2002;
Yatim and Lakkis, 2015).
1.1.2 Adaptive Immune System
The adaptive immune system generates a wide array of T cell receptors (TCR)
and B cell receptors (immunoglobulin) through random gene rearrangements (Tomar and
De, 2014; Yatim and Lakkis, 2015). As a result, receptors of the adaptive immune system
are highly polymorphic, manifest low affinity for their ligands, but provide great breadth
of repertoire (Tomar and De, 2014). Consequently, the adaptive immune response is
slower, but provide breadth and memory. B cells express a B cell receptor
immunoglobulin that recognizes the three-dimensional structure of antigens. As B cells
develop, the immunoglobulin gene undergoes a series of recombination events of its
Variable (V), Diversity (D), and Joining (J) regions (termed V(D)J recombination) that
allows for each B cell receptor to recognize a unique antigen (Roth, 2014). V(D)J
recombination allows for a limited number of V, D, and J regions of DNA to be
recombined into a large number of different immunoglobulins (Roth, 2014; Tomar and
De, 2014; Yatim and Lakkis, 2015).This process of immunoglobulin gene recombination
allows for B cells to respond to a much broader array of antigens compared to PRRs of
the innate immune system. Once the B cell receptor interacts with its cognate antigen, the
B cell becomes activated and begins proliferating and producing antibodies that
recognize their antigenic epitope. During proliferation, B cell antibodies will undergo
somatic hypermutation, a process through which the variable region of the antibody gene
4

is randomly mutated resulting a higher affinity antibody (Di Noia and Neuberger, 2007;
Tomar and De, 2014).
T cells express a T cell receptor (TCR) that also undergoes V(D)J recombination,
though not somatic hypermutation, allowing T cells to recognize a similarly large array of
antigens (Roth, 2014). The difference is that the TCR recognizes antigen complexed with
self-major histocompatibility complex (MHC), or self-MHC-like, molecules on APCs
(Malissen et al., 2014). Activated T cells perform a variety of functions, depending on the
subset of T cell that is activated. The major T cell subsets are discussed further in the next
section.
Following expansion in response to antigenic activation during an immune
response, most T cells and B cells die, but a few survive to become memory cells.
(Quintin et al., 2014; Sun et al., 2014). Immune memory allows for the immune system to
respond quickly and with more intensity to a secondary infection.
1.2 T cells
T cells, which express a T cell receptor (TCR), include αβ T cells, γδ T cells,
natural killer T (NKT) cells, and mucosa-associated invariant T (MAIT) cells.
Conventional αβ T cells are restricted to recognizing peptide antigens presented in
complex with MHC I or MHC II. NKT cells, MAIT cells, and γδ T cells, vary in the
types of antigens recognized by their limited repertoire of TCRs and are considered to
function between the innate and adaptive immune system (Sun et al., 2014). NKT cells,
which express an invariant TCR (Vα14-Jα18 α-chain in mice and Vα24-Jα18 α-chain in
humans; known as Type I NKT cells) or a non-invariant TCR (known as Type II NKT
cells) are restricted to interacting with lipid antigens presented on the MHC I-like
5

molecule CD1d (Kumar et al., 2017; Macho-Fernandez and Brigl, 2015; Trottein and
Paget, 2018). MAIT cells express an invariant TCR (Vα19-Jα33 α-chain in mice and
Vα7.2-Jα33 α-chain in humans) and are restricted to non-peptide small-molecule antigens
presented on the MHC class I-like molecule MR1 (Trottein and Paget, 2018; Xiao and
Cai, 2017). Putative antigens that γδ T cells have been found to recognize include
antigens associated with MHC I-like molecules, as well as antigens not associated with
MHC molecules. These putative antigens vary from peptides to lipids to proteins (Born et
al., 2013; Champagne, 2011).
αβ T cells, henceforth called T cells, can be split into two distinct subsets based
on the expression of the coreceptors CD4 or CD8. The TCR recognizes peptide antigen
bound to the MHC in mice, or human leukocyte antigen (HLA) in humans on the surface
of APCs (Wieczorek et al., 2017). There are two classes of MHC, class I and class II
(Rock et al., 2016). MHC class I (HLA-A, -B, and -C in humans) binds small intrinsic
peptides (about 8-10 amino acids in length) is expressed ubiquitously among cell types
(Rock et al., 2016; Wieczorek et al., 2017). MHC class II (HLA-DR, -DP, -DQ in
humans) binds to peptides (about 13-25 amino acids in length) from exogenous antigens
that have been phagocytosed and processed within an APC (Rock et al., 2016; Wieczorek
et al., 2017). The coreceptor (CD4 or CD8) expressed on the surface of the T cell
determines which MHC the T cell will recognize; CD4 recognizes determinants on MHC
class II and CD8 recognizes determinant on MHC class I (Rock et al., 2016).
1.2.1 T cell development
T cells begin as hematopoietic stem cells generated in the bone marrow. These
stem cells enter the thymus as thymic seeding progenitor cells. In the thymus, the
6

progenitor cells will undergo successive developmental steps during the CD4-CD8double-negative (DN) stage, which can be divided into four phases based on the
expression of CD25 and CD44: DN1, CD25-CD44+; DN2, CD25+CD44+; DN3,
CD25+CD44-; DN4, CD25-CD44- (Lucas et al., 2016). During the transition from DN2 to
DN3, T cell receptor rearrangement begins and developing thymocytes commit to either
γδ T cells or αβ T cells. Between DN2 and DN3, the γ, δ, and β chain genes undergo
rearrangement (Carpenter and Bosselut, 2010). If the γ and δ chains of the TCR
successfully rearrange before the β chain, the cell becomes a γδ T cell (Carpenter and
Bosselut, 2010). If the β chain successfully rearranges first, then the cell becomes an αβ T
cell and enters the DN3 stage (Rothenberg, 2011). A pre-α chain pairs with the β chain to
create a surface pre-TCR, and the cell enters the DN4 stage (Rothenberg, 2011). In DN4,
CD4 and CD8 are expressed to create a CD4+CD8+ double-positive (DP) cell. During this
DP stage, the α-chain of the TCR rearranges and is expressed, creating a mature TCR.
The TCR on DP cells then interacts with self-peptide:MHC complexes (Carpenter and
Bosselut, 2010). DP cells that recognize self-peptide:MHC with low affinity are
positively selected, whereas those manifesting high affinity undergo negative selection
and cell death (Carpenter and Bosselut, 2010). During this time, either the CD4 or CD8
coreceptor will be downregulated, creating a CD4 or CD8 single-positive (SP) T cell.
Mature CD4+ or CD8+ T cells will then leave the thymus and enter the periphery (Koch
and Radtke, 2011; Shah and Zuniga-Pflucker, 2014; Zuniga-Pflucker, 2004).
1.2.2 CD4+ T cells
CD4+ T cells are known as helper T (Th) cells because they secrete cytokines that
promote the effector function of other immune cells. CD4+ T cells can be divided into
7

different subsets depending on the transcription factor that the cell expresses. Each subset
secretes a different combination of effector cytokines. Subsets are identified by those
secreted cytokines and their specific transcription factor (Geginat et al., 2013). Th1 cells
express the transcription factor T-bet, which induces the expression of interferon-γ (INFγ), the signature cytokine produced by Th1 cells. INF-γ promotes the production of
immunoglobulin IgG2a, induces antiviral responses, and activates macrophages to help
protect against microbial pathogens and tumors through upregulation of phagocytosis and
antigen presentation (Finkelman et al., 1988; Männel and Falk, 1983; Schoenborn and
Wilson, 2007; Szabo et al., 2000; U. Boehm et al., 1997). Th1 cells also produce IL-2,
which promotes T cell activation and effector function (Geginat et al., 2013; Liao et al.,
2013).
Th2 cells express the transcription factor GATA-3, which induces the expression
of IL-4 and IL-5 (Zheng and Flavell, 1997). IL-4 induces antibody class switching in B
cells to IgE, while IL-5 induces the proliferation of B cells and eosinophils (Caza and
Landas, 2015; Takatsu, 2011).
Th17 cells express the transcription factors RORγT and RORα (Yang et al.,
2008). These transcription factors upregulate the expression of IL-17 and IL-17F, which
induce the expression of antimicrobial peptides and inflammatory cytokines and
chemokines (Kolls and Lindén, 2004; Liang et al., 2006). Th17 cells have been
implicated in the pathogenesis of autoimmune diseases such as the mouse model of
multiple sclerosis, experimental autoimmune encephalomyelitis (Komiyama et al., 2006).
Regulatory T (Treg) cells are CD4+ T cells that express the transcription factor
FoxP3 and suppress the immune response in part through production of the
8

immunosuppressive cytokine IL-10. As such, Tregs help to reduce the effector function
of immune cells and maintain tolerance for the prevention of autoimmune disease (Caza
and Landas, 2015; Geginat et al., 2013).
Since CD4+ T cells depend on cytokines to promote and maintain subset
differentiation, it is also possible for CD4+ T cells to switch between subsets. This ability
to switch subsets is called plasticity, and some subsets are more sensitive to it than others.
Th2 cells can easily become Th1 cells if IL-4 is removed from the culture media, though
this switch may not be as easy the further these cells are from their initial activation
(Murphy et al., 1996). Tregs and Th17 cells show a similar degree of plasticity (Caza and
Landas, 2015; Xu et al., 2007).
1.2.3 CD8+ T cells
CD8+ T cells are an important defense against intracellular pathogens such as
viruses and intracellular bacteria, as well as tumors. Like CD4+ T cells, there is evidence
for the existence of CD8+ T cell subsets that produce a variety of cytokines when
activated, and therefore perform many different functions, though these subsets are not as
well understood as the CD4+ subsets (Mittrucker et al., 2014). The major CD8+ T cell
subset, and the one that is best understood, is called a cytotoxic T lymphocyte (CTL).
Once activated, CTLs will secrete proinflammatory cytokines INF-γ and tumor necrosis
factor α (TNF-α), which increase both the innate and adaptive immune response.
Activated CTLs will also induce death in cells that express their cognate antigen on MHC
class I. After recognizing the antigen, CTLs release granules containing granzymes and
perforin. Granzymes are serine proteases that enter the target cell through pores created
by perforin. Once in the cell, the granzymes will cleave proteins and induce apoptosis.
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CTLs also kill by surface expression of Fas-ligand. CTLs are able to combat intracellular
pathogens by inducing death in the infected cell, preventing the replication and spread of
the pathogen (Mittrucker et al., 2014; Tscharke et al., 2015).
1.2.4 T cell activation
Naïve T cells need to be activated to perform their effector function. Activation
occurs when the naïve T cell receives two signals; one from the TCR and another from
the costimulatory receptor CD28. The TCR exists in a complex with other proteins, of
which the CD3 molecules (CD3 γ, δ, ε, and ζ) are important for signaling (Borst et al.,
1984; Samelson et al., 1986). When the TCR and CD4 or CD8 bind to the peptide:MHC
complex, the lymphocyte-specific protein tyrosine kinase (Lck) bound to CD4 or CD8
will phosphorylate CD3. The protein ζ-associated protein of 70 kDa (Zap70) is recruited
to the phosphorylated CD3ζ, which leads to the phosphorylation of linker for activation
of T cells (LAT) (Chan et al., 1992; Zhang et al., 1998a). Once activated, LAT will
transduce a number of signals that ultimately lead to the activation of transcription factors
activator protein 1 (AP-1) and nuclear factor of activated T cells (NFAT) (Smith-Garvin
et al., 2009). As the TCR and coreceptors are engaged with the peptide:MHC complex,
CD28 will bind to CD80 or CD86 on the APC, which results in a phosphorylation
cascade leading to the activation of nuclear factor kappa-light-chain-enhancer of
activated B cells (NFκB). These transcription factors will upregulate the expression of
genes needed for the cell to proliferate and perform its effector function (Malissen and
Bongrand, 2015; Malissen et al., 2014). IL-2 is one of the genes expressed as a result of
NFAT and AP-1 activation (Liao et al., 2013). IL-2 promotes T cell proliferation, effector
function, and induces glycolysis (Friedmann et al., 1996; Liao et al., 2013; Lin et al.,
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2012). Not only is glycolysis induced late in T cell activation through IL-2 signaling, it is
also induced within hours after TCR stimulation as a result of pyruvate dehydrogenase
kinase 1 activation and reduction of pyruvate import into mitochondria (Menk et al.,
2018).
1.2.4.1 Role of lipid rafts in T cell signaling and activation
Lipid rafts, also called membrane rafts, are cholesterol-rich microdomains found
in cellular membranes. These rafts are typically considered to be small regions of
membrane, ranging from 10 nm to 200 nm, which includes caveolae and caveolin-rich
regions of the membrane (Anderson and Jacobson, 2002; Pike, 2006). Though the
composition of rafts is heterogenous and difficult to define, they are typically enriched in
sphingolipids and sterols. Being enriched with these components allows rafts to be
conducive for protein-protein interactions, as well as protein-lipid interactions (Pike,
2006). This allows the clustering of proteins, which can stabilize multi-protein
interactions and promote the compartmentalization of cellular processes. Stabilization of
the rafts can also occur through interactions between raft-associated proteins and the
cytoskeleton (Pike, 2006). While rafts are typically small, they can be recruited and
stabilized into larger membrane domains (Anderson and Jacobson, 2002; Pike, 2006).
Among the signaling proteins that have been described as localizing to rafts in T cells are
Lck, LAT, TCR, CD28, and CD3 complex (Varshney et al., 2016; Zumerle et al., 2017).
Relevant to this dissertation is caspase-8 complexed to its activator, c-FLIP, which has
been described in lipid rafts in activated T cells (Misra et al., 2007).
A specific lipid raft in T cells is the immunological synapse. The immune synapse
is formed where the TCR interacts with the MHC-peptide complex on an antigen11

presenting cell, inducing activation of the T cell (Huppa and Davis, 2003). Many
different proteins are involved in this interaction and nearly all the T cell-relevant
proteins are found within lipid rafts at the immune synapse. These include the TCR, CD3
complex, Lck, LAT, and CD28 (Varshney et al., 2016; Zumerle et al., 2017). While some
of these proteins (e.g. TCR and CD28) have transmembrane domains, others, such as Lck
and LAT, are recruited to the cell membrane and lipid rafts by posttranslational addition
of fatty acids; LAT can be palmitoylated, whereas Lck can be both acylated and
myristoylated (Zhang et al., 1998b). While membrane rafts are important for T cell
activation, their function in other aspects of T cell biology is poorly understood.
1.3 Cytokines
Cytokines are small secreted immunomodulatory proteins that act in a paracrine
or autocrine manner similar to hormones. Cytokines can be produced by many different
cell types including immune cells, fibroblasts, and endothelial cells.
Various groups of cytokines have been identified based on similarities in function
or binding to common receptors. The common cytokine-receptor gamma-chain (γc)
family is very important in regulating the proliferation and survival of T cells. These
cytokine receptors are all heterodimeric or heterotrimeric and contain the γc (also known
as CD132) as one of the subunits. The γc cytokines include interleukin (IL)-2, IL-4, IL-7,
IL-9, IL-15, and IL-21. Some of the γc cytokines are important in the differentiation and
proliferation of effector T cells (IL-2, IL-4, IL-9, and IL-21), while others are important
in the homeostasis and survival of memory and naïve T cells (IL-7 and IL-15) (Rochman
et al., 2009). Two of these cytokines, IL-2 and IL-15, are unique because they are the γc
cytokines with trimeric receptors. Those receptors contain the γc, the IL-2 receptor β (IL12

2Rβ or CD122), and the IL-2 receptor α (IL-2Rα or CD25) or IL-15Rα, for respectively,
IL-2 or IL-15 (Waldmann, 2002). Though they share a similar receptor, IL-2 and IL-15
differ in their contributions to T cell survival.
1.3.1 IL-2 signaling
IL-2 was originally identified as a growth factor for T cells, which remains one of
the best understood roles of IL-2 (Morgan et al., 1976). Both CD4+ and CD8+ T cells
produce IL-2, though CD4+ T cells produce IL-2 to a greater extent (Paliard et al., 1988).
IL-2 binds to the trimeric IL-2R, whose expression increases following T cell activation
(Cantrell and Smith, 1983). Binding to the IL-2R induces a signaling cascade through the
JAK/STAT pathway (primarily through JAK1 and JAK3, and subsequently STAT5 and
STAT3), the PI3K pathway, and the ERK pathway (Fig. 1.1) (Johnston et al., 1995; Ring
et al., 2012; Waldmann, 2015). PI3K signaling leads to mTOR activation, and the
upregulation of glycolysis (Liao et al., 2013; Ray et al., 2015; Spolski et al., 2018; van
der Windt et al., 2012). Through the upregulation of glycolysis, IL-2 increases the
synthetic capacity of the cell to allow rapid proliferation during an immune response
(Ray et al., 2015). After induction of glycolysis, IL-2 is important for maintaining
proliferation and function of effector CD8+ T cells, as well as many of the CD4+ T cell
subsets.
In addition to its role in T cell proliferation, IL-2 has a critical role in cell death.
In effector T cells, IL-2 increases sensitivity to apoptosis by activation-induced cell death
and Fas (CD95)-mediated death (Lenardo, 1991; Refaeli et al., 1998). In this regard, a
striking and unanticipated finding was that mice deficient in CD25 accumulate T cells
and develop autoimmune symptoms, further supporting the fact that IL-2 is important in
13

T cell death (Willerford et al., 1995). While it is clear that IL-2 has a role in both
proliferation and cell death, the mechanism by which IL-2 increases sensitivity to death is
not well understood.

Figure 1.1: Signaling through the IL-2 and IL-15 receptors

1.3.2 IL-15 signaling
Similar to IL-2, IL-15 binds to a trimeric receptor composed of both the γc and
CD122 subunits, as well as IL-15Rα. IL-15 can bind to the IL-15R through cispresentation (when the IL-15Rα is on the cell receiving the signal) or through transpresentation (when IL-15 is bound to the IL-15Rα and presented by a neighboring cell)
and can be produced by monocytes, dendritic cells, and fibroblasts (McInnes and Liew,
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1998a; Waldmann, 2015). IL-15 binding initiates a signaling cascade similar to IL-2,
activating JAK1 and JAK3, followed primarily by STAT5 (Ring et al., 2012; Rochman et
al., 2009). Signaling through the IL-15 receptor also leads to PI3K and ERK signaling
(Fig. 1.1) (Ring et al., 2012; Waldmann, 2015). Originally described as a proliferative
cytokine for T cells, like IL-2, it was later shown that IL-15 also promotes survival in T
cells by reducing restimulation-induced cell death, which is promoted by IL-2 (Burton et
al., 1994; Grabstein et al., 1994; Marks-Konczalik et al., 2000). The increased survival
promoted by IL-15 is related to an important function of the cytokine, homeostatic
proliferation and maintenance of memory CD8+ T cells (Tan et al., 2002). Due to its
ability to maintain T cell populations for extended periods of time, as well as activate NK
cells, IL-15 can induce tissue damage when it is over expressed. This is apparent in the
synovial tissue of patients with rheumatoid arthritis, where the synovium contains high
levels of IL-15 and low levels of IL-2, which can lead to prolonged T cell expansion and
survival, contributing to the tissue damage in rheumatoid joints (McInnes and Liew,
1998b).
Due to the similarities in signaling with IL-2, there has been much interest in
trying to understand the cause for the differences in phenotypes induced by IL-2 and IL15 signaling. It is thought that differences in receptor binding strength, tissue context, and
activation state (in the context of T cells) all play a role in determining these differences
(Castro et al., 2011; Ring et al., 2012; Waldmann, 2015). One difference of interest is in
the susceptibility to cell death induced by IL-2 versus IL-15. Previous studies from our
group have shown the decreased death in IL-15-cultured T cells to be due to inactivation
of caspase-3 by the posttranslational modification S-nitrosylation of the critical cysteine
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in the enzymatic pocket of caspase-3. (Saligrama et al., 2014). Additional studies have
revealed a parallel between the increased T cell survival with IL-15 and its promotion of
oxidative phosphorylation and fatty acid utilization (O'Sullivan et al., 2014; van der
Windt et al., 2012). However, it is not known how, or if, the metabolic differences
between IL-2-cultured and IL-15-cultured T cells directly influence sensitivity to cell
death.
1.4 Immunometabolism
Metabolism is the combination of anabolic and catabolic processes within the cell.
The anabolic processes are those used to generate sugars, fats, amino acids, nucleotides,
among other molecules that are necessary for maintenance of cell integrity and
proliferation. Those necessary substrates that cannot be made through anabolic processes
are transported into the cell from the environment. The catabolic processes are those that
break down large molecules into smaller components, either to feed the anabolic
processes or to generate energy.
In most cells, glycolysis and oxidative phosphorylation are the major pathways
used to generate ATP. Glucose is catabolized to pyruvate and then acetyl-CoA to fuel the
tricarboxylic acid (TCA) cycle in the mitochondria. The energy-carrying products of
glycolysis and the TCA cycle are NADH and FADH2, whose electrons fuel the electron
transport chain (ETC). The ETC pumps protons across the inner membrane of the
mitochondria to produce an energy potential. This energy potential is used by ATP
synthase, or complex V of the ETC, to create ATP. Fatty acid oxidation also contributes
to ATP generation through catabolism of fatty acids such as palmitate, which results in
the production of NADH, FADH2, and acetyl-CoA to fuel the ETC.
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In addition to its metabolism in generating ATP, glucose utilization can also be
diverted into the pentose phosphate pathway to create intermediates needed for lipid,
protein, and nucleotide synthesis. Glucose can also be stored to make glycogen in muscle
cells, astrocytes, hepatocytes, and dendritic cells, which is then used to fuel the TCA
cycle after being catabolized back to glucose (Roach et al., 2012; Thwe et al., 2017).
When glucose is not fueling the TCA cycle, immune cells tend to use glutamine and fatty
acids to maintain OXPHOS.
Metabolism plays an important role in the function immune cells, and the
metabolites used can dictate which function the cells have. Many techniques have been
developed to determine the metabolic pathways used by cells. One of the most powerful
tools is the use of heavy isotope-labeled metabolites in cell culture media, combined with
mass spectrometry. Heavy isotope-labeled metabolites contain stable, heavy isotopes of
carbon, nitrogen, and/or hydrogen that can be differentiated from their normal
counterparts by mass spectrometry. When these labeled metabolites are added to the
culture medium, the cells will incorporate those heavy atoms as they normally would, but
now the atoms can be tracked. This allows for the identification of the metabolic
pathways to which a cell will divert a given metabolite (Jang et al., 2018). Techniques
such as this help to identify how cells are able to use different metabolites under different
growth conditions. The following sections describe the major metabolic pathways of
immunometabolism, and how those pathways dictate immune cell function, with an
emphasis on T cells.
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1.4.1 Glycolysis
Glycolysis is a catabolic process that converts one 6-carbon glucose molecule into
two 3-carbon pyruvate molecules using 2 ATP molecules (Fig. 1.2). The process begins
with the transport of glucose into the cell through one of fourteen glucose transporters.
After entering the cell, glucose is rapidly phosphorylated by hexokinase, resulting in
glucose-6-phosphate (G6P). This phosphorylation event uses the first ATP molecule.
G6P is converted to fructose-6-phosphate by phosphoglucose isomerase. The second
ATP is used by phosphofructokinase to convert F6P to fructose-1,6-bisphosphate
(F1,6P). At this point, the six-carbon sugar F1,6P is converted into two three-carbon
sugars by aldolase. This reaction creates one dihydroxyacetone phosphate (DHAP) and
one glyceraldehyde-3-phosphate (GAP). DHAP is rapidly converted to GAP by triose
phosphate isomerase. The three-carbon sugar GAP is further converted by
glyceraldehyde-3-phosphate dehydrogenase into 1,3-bisphosphoglycerate (1,3-BPG),
which is then converted to 3-phosphoglycerate (3-PG) by phosphoglycerate kinase,
generating a molecule of ATP in the process. 3-PG is converted into 2-phsophoglycerate
(2-PG) by phosphoglycerate mutase. Enolase converts 2-PG into phosphoenolpyruvate
(PEP), which is finally used by pyruvate kinase to make pyruvate. Thus, one molecule of
glucose results ultimately in two pyruvate molecules.

18

Figure 1.2: Steps of glycolysis

1.4.1.1 Importance of glycolysis in immune cells
Glycolysis plays an important role in the activation and effector function of many
immune cells. Dendritic cells undergo a glycolytic burst after activation by TLR antigens
(Everts et al., 2014). T cells, NK cells, B cells, and macrophages all undergo a similar
switch to glycolysis after activation (Caro-Maldonado et al., 2014; Hume et al., 1978;
Rodriguez-Prados et al., 2010; Roos and Loos, 1973a). For T cells, glycolysis is
maintained by effector CD8+ T cells, as well as Th1, Th2, and Th17 CD4+ T cells
(Michalek et al., 2011; van der Windt et al., 2012). Whereas glycolysis does generate
some ATP (a net yield of 2 ATP per glucose molecule), the reason for the increase in
glucose catabolism with immune cell activation is thought to be primarily for the
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generation of metabolic intermediates needed to fuel the anabolic processes needed for
rapid cell growth and effector function.
Many of the glycolytic intermediates are used in other metabolic pathways. G6P
can be used in both glycogen synthesis and to fuel the pentose phosphate pathway. The
primary non-glycolytic function for G6P is in the synthesis of nucleotide precursors and
the reducing agent NADPH through the pentose phosphate pathway. G6P can also be
converted to glycogen, a branched polymer of glucose. Glucose storage as glycogen is
most well known in muscle and liver cells, though recent studies have shown glycogen
metabolism to play an important role in dendritic cell and T cell biology (Ma et al., 2017;
Thwe et al., 2017). Dendritic cells have been shown to generate and store glycogen,
which is used to support effector functions such as cytokine production and antigen
processing and presentation. Memory T cells have also been found to store glucose as
glycogen, which is catabolized to G6P to fuel the pentose phosphate pathway.
Amino acid metabolism is another major use of glucose, fed by 3-PG (serine
biosynthesis), PEP (tryptophan biosynthesis), and pyruvate (alanine biosynthesis).
Pyruvate, along with contributing to alanine metabolism, is converted into two important
metabolites, lactate and acetyl-CoA. Pyruvate is converted into lactate by lactate
dehydrogenase, which uses NADH as a cofactor. This replenishes NAD+, which can then
be used as an electron acceptor in glycolysis and the TCA cycle. Generally, lactate is
considered a byproduct of highly glycolytic cells. Recently, however, lactate has been
shown to modulate CD8+ T cells function, causing the loss of cytolytic activity and
migratory function (Haas et al., 2015). Macrophages are polarized toward an M2
phenotype in high lactate environments (Pucino et al., 2017). Pyruvate is converted to
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acetyl-CoA by pyruvate dehydrogenase. Acetyl-CoA is the base substrate for fatty acid
synthesis and can be used to generate lipids and fatty acids for the cell. Acetyl-CoA is
also one of the primary carbon donors for the TCA cycle.
1.4.2 Tricarboxylic acid cycle
Also known as the Krebs cycle or the citric acid cycle, the tricarboxylic acid
(TCA) cycle is the primary method used by cells to shuttle electron donors, NADH and
FADH2, into the electron transport chain at, respectively, complexes I and II. This results
in a net yield of 32 ATP, making the TCA cycle plus OXPHOS the major source of ATP
in the cell.
The TCA cycle occurs in the matrix of the mitochondria (Fig. 1.3). Pyruvate is
transported into mitochondria and converted into acetyl-CoA by pyruvate dehydrogenase.
Acetyl-CoA can then enter the TCA cycle by reacting with oxaloacetate in a process
catalyzed by citrate synthase. Acetyl-CoA is attached to oxaloacetate before the
coenzyme A group is removed. The final product is citrate, which is then isomerized to
isocitrate by aconitase. Isocitrate dehydrogenase decarboxylates isocitrate to create αketoglutarate and a molecule of NADH. Another NADH molecule is generated as αketoglutarate is converted to succinyl-CoA by α-ketoglutarate dehydrogenase. SuccinylCoA is converted to succinate by succinyl-CoA synthetase, creating succinate. Succinate
is converted to fumarate by succinate dehydrogenase, an enzyme that is part of complex
II of the electron transport chain. This reaction generates one molecule of FADH2, which
is used by complex II to transfer electrons to the electron transport chain. Fumarase
creates catalyzes the reaction of fumarate to malate, which is followed by the conversion
of malate to oxaloacetate by malate dehydrogenase. This final step of the TCA cycle
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generates a final molecule of NADH, and completes the cycle, allowing oxaloacetate to
be regenerated to react with acetyl-CoA once more. Since two acetyl-CoA molecules are
generated from one glucose molecule, the full catabolism of glucose results in 6 NADH
molecules and 2 FADH2 molecules to be generated from the TCA cycle.

Figure 1.3: Steps of the tricarboxylic acid cycle

1.4.2.1 Importance of the TCA cycle in immune cells
Carbons can enter and exit the TCA cycle at nearly every intermediate. In fact,
immune cells that undergo a high amount of glucose utilization for proliferation need to
fuel the TCA cycle with other metabolites, so the glycolytic intermediates can be used for
biosynthetic purposes. Citrate is at the first major junction of the TCA cycle. After being
generated by citrate synthase, citrate can exit the mitochondria and be converted back to
acetyl-CoA, which can then be used for fatty acid synthesis to generate lipids. While it
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may seem wasteful for the cell to generate citrate from acetyl-CoA only to turn that
citrate back into acetyl-CoA, cells that catabolize a lot of glucose can send those carbons
to feed the TCA cycle and generate the lipids needed to support growth and proliferation.
Fatty acids generated through this pathway can also be used to support the TCA cycle.
Fatty acid synthesis supported by glycolysis is important in the differentiation of CD4+ T
cells into either Th17 cells or Treg cells. Th17 cells are shifted toward a Treg phenotype
when acetyl-CoA carboxylase 1 (ACC1), an enzyme involved in fatty acid synthesis, is
inhibited. Tregs rely on the oxidation of externally derived fatty acids, further indicating
the importance of fatty acid synthesis in Th17 development and function (Berod et al.,
2014a).
Citrate and succinate also play important roles in inflammatory macrophages.
When citrate accumulates in bone marrow-derived macrophages (BMDM) activated by
LPS, it can be converted to itaconate, which was found to cause an accumulation of
succinate by inhibiting succinate dehydrogenase (Lampropoulou et al., 2016). Reducing
the production of itaconate led to an increase in succinate dehydrogenase activity, a
decrease in succinate levels, and in increase HIF-1α and the production of inflammatory
cytokines such as IL-1β and IL-18. An earlier study of succinate metabolism in
macrophages had shown that after LPS stimulation, BMDM use γ-aminobutyric acid
(GABA) to make succinate (Tannahill et al., 2013). Reducing succinate generated from
GABA led to a reduction in HIF-1α and IL-1β production. Although a reduction in
succinate led to two opposing results, the flow of carbons into the TCA cycle was
different between studies and this may be more important than the levels of succinate in
determining macrophage effector function. Together, these studies demonstrate that
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citrate, succinate, and carbon flow through the TCA cycle are important factors in
macrophage and T cell function.
An additional notable metabolite is α-ketoglutarate, as it is the second major entry
point into the TCA cycle for carbons in immune cells. Glutamine is known to be critically
important for supporting immune cell function, and a large reason for that is because
glutamine is converted to glutamate, which is then used to generate α-ketoglutarate as a
fuel source for the TCA cycle.
1.4.3 Glutaminolysis
Glutamine is an important amino acid, as it can be used to generate many
different molecules. Glutamine is transported into the cell by a variety of transporters
(ASCT2 is an important glutamine transporter on T cells) and can then be used to
generate purines, pyrimidines, amino acids, or glutamate (Nakaya et al., 2014; Pochini et
al., 2014). Carbons from glutamate can be incorporated into the TCA cycle through αketoglutarate, or through succinate. The primary route of glutamine into the TCA cycle is
through the conversion to glutamate by glutaminase. Glutamate dehydrogenase then
converts glutamate to α-ketoglutarate, which then continues into the TCA cycle to be
converted into glutamate.
The other path for glutamine to enter the TCA cycle is through conversion of
glutamate into GABA, a neuroinhibitory neurotransmitter. Glutamate is converted into
GABA by glutamate decarboxylase, and then converted into succinate semialdehyde.
Finally, succinate semialdehyde is converted into succinate and can enter the TCA cycle
or perform other functions. This non-canonical pathway for succinate synthesis in
immune cells has been shown in BMDM. GABA was detected by mass spectrometry in
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BMDM and 13C-labeled succinate was detected after culturing BMDM with 13C-labeled
glutamine, indicating the use of this pathway in immune cells (Tannahill et al., 2013).
GABA has also been implicated in modulating T cell function, having been reported to
reduce T cell proliferation and inhibit Th1 cell responses (Bhat et al., 2010; Bjurstom et
al., 2008; Tian et al., 2004).
1.4.4 Fatty acid oxidation
Fatty acid oxidation, also known as β oxidation, is the process through which fatty
acids are broken down into individual acetyl-CoA molecules that can enter the TCA
cycle. Fatty acid oxidation begins in the cytosol with the addition of coenzyme A (CoA)
to a fatty acid by acyl-CoA synthetase. This process creates an acyl-CoA and requires
one ATP molecule to complete. Fatty acid oxidation occurs in the mitochondria, but acylCoA molecules cannot be transported into the mitochondria and must first be converted
to acyl-carnitine. These acyl-carnitine molecules can be transported into the
mitochondria. Carnitine palmitoyltransferase 1 and 2 (CPT1 and CPT2) are the enzymes
responsible for translocating fatty acids into the mitochondria. CPT1 is located on the
external side of the inner mitochondrial membrane and is responsible for converting the
acyl-CoA into acyl-carnitine. The acyl-carnitine can then be shuttled across the inner
mitochondrial membrane by a carnitine carrier protein. CPT2, located in the
mitochondrial matrix, converts acyl-carnitine back into acyl-CoA. The free carnitine is
then transported out of the matrix by the carnitine carrier protein.
Once in the mitochondrial matrix, the acyl-CoA undergoes fatty acid oxidation.
This is a four-step process that results in the release of one acetyl-CoA molecule from the
fatty acid chain. Fatty acid oxidation generates energy not only by adding acetyl-CoA to
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the carbon pool for the TCA cycle, but also through the release of that acetyl-CoA. Two
steps in the process, reactions catalyzed by acyl-CoA dehydrogenase and 3-Lhydroxyacyl-CoA dehydrogenase, generate FADH2 and NADH, respectively. These
cofactors can then donate electrons to the ETC. Fatty acid oxidation ends with the
addition of a CoA molecule onto the acyl chain, regenerating acyl-CoA. The acyl-CoA,
now two carbons shorter due to the release of acetyl-CoA, can undergo another round of
fatty acid oxidation. The whole process repeats until the fatty acid is fully oxidized.
1.4.4.1 The role of fatty acid oxidation in immune cells
Fatty acid oxidation is generally considered a contributor to the anti-inflammatory
state of immune cells. In macrophages, CPT1A (an isoform of CPT1) expression has
been shown to be correlated with increased fatty acid oxidation. Overexpression of the
protein in macrophages resulted in the increase of fatty acid oxidation and the decrease of
pro-inflammatory molecules, such as IL-1β (Malandrino et al., 2015).
In T cells, fatty acid oxidation has been shown to be important for both memory T
cell and Treg cell generation. CD8+ T cells that have been shifted to a memory phenotype
through supplementation of the culture medium with IL-15 display increased fatty acid
oxidation and OXPHOS, which is important for maintaining that memory state. Memory
CD8+ T cells use glucose to generate fatty acids, which are then used to support
OXPHOS via fatty acid oxidation (O'Sullivan et al., 2014). IL-15-generated memory-like
CD8+ T cells also express a greater amount of CPT1A compared to effector cells and
blocking CPT1A with the drug etomoxir results in a decrease in OXPHOS (O'Sullivan et
al., 2014; van der Windt et al., 2012). Treg cells generated in vitro were shown to have
increased OXPHOS and fatty acid oxidation, as measured by oxidation of radiolabeled
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palmitate, which was decreased with etomoxir treatment. Th17 cells, compared to Treg
cells, undergo less fatty acid oxidation and more glycolysis (Michalek et al., 2011).
1.4.5 Oxidative phosphorylation
Unlike the previously mentioned metabolic pathways, oxidative phosphorylation
(OXPHOS) is not a series of enzymatic reactions that are responsible for the catabolism
or anabolism of metabolites. OXPHOS encompasses glycolysis, the TCA cycle, and
electron transport. The name oxidative phosphorylation refers to the oxidation of glucose
and TCA intermediates which results in the phosphorylation of ADP to create ATP. The
key to the whole process is the transfer of electrons between protein complexes and
ultimately to oxygen. This process results in the generation of a proton gradient across
the inner mitochondrial membrane which is needed for complex V, or ATP synthase, to
generate ATP from ADP. Having covered the “oxidative” half of OXPHOS in the
previous sections, the next section will focus on the second half, that is electron transport
and ATP synthesis.
1.4.5.1 The electron transport chain
The electron transport chain (ETC) is composed of five different protein
complexes in the inner mitochondrial membrane: complex I (NADH-coenzyme Q
oxidoreductase), complex II (succinate-coenzyme Q oxidoreductase), complex III
(coenzyme Q-cytochrome c oxidoreductase), complex IV (cytochrome c oxidase), and
complex V (ATP synthase). Electrons removed at various points during glycolysis, the
TCA cycle, and fatty acid oxidation, are transported to the ETC in the form of the
cofactors NADH and FADH2 (Fig 1.4). NADH donates electrons to complex I, where the
electrons traverse the complex through a series of coenzymes and iron-sulfur redox
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centers before being transferred to coenzyme Q (CoQ). The process of moving electrons
from NADH to CoQ results in the translocation of protons from the matrix of the
mitochondria to intermembrane space. Complex II, which also contains succinate
dehydrogenase, transfers electrons from succinate to CoQ, using FAD as the initial
cofactor. Electrons are transferred to FAD to generate FADH2, which then transfers the
electrons to redox centers in the complex before finally reducing oxidized CoQ. Reduced
CoQ, generated either at complex I or complex II, transports electrons to complex III
through the lipid bilayer. Complex III then transfers the electrons from CoQ to
cytochrome C, translocating protons to the intermembrane space in the process.
Cytochrome c then transfers the electrons to complex IV, where the electrons are used to
reduce oxygen to water. Complex IV also translocates protons to the intermembrane
space in the process of reducing oxygen.
The purpose of the electron transport chain is to translocate protons from the
mitochondrial matrix to the intermembrane space. This creates an electrochemical
gradient of protons and charge, with the intermembrane space being much more
positively charged than the matrix. This gradient, called the proton motive force or
mitochondrial membrane potential, is what allows complex V of the ETC to generate
ATP. Complex V allows protons to flow back down this gradient while using the energy
of that proton flow to phosphorylate ADP. Protons enter the matrix, where they are again
translocated through the complexes of the ETC, replenishing the electrochemical
gradient.
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Figure 1.4: Electron transport chain

1.4.5.2 The role of oxidative phosphorylation in immune cells
OXPHOS is often referred to as an opposing metabolic state from glycolysis in
immunometabolism literature. This can be misleading, as OXPHOS can encompass
glycolysis through the oxidation of carbons derived from glucose. Therefore, the term
OXPHOS has taken on a related meaning of mitochondrial respiration. Since oxygen is
the final electron acceptor in OXPHOS, measurements of oxygen consumption by cells
can be used as a proxy measurement of mitochondrial respiration and electron transport.
Electron transport is directly tied to the TCA cycle through the oxidation of FADH2 and
NADH, so an increase in oxygen consumption is considered to be linked to an increase in
carbon flow through the TCA cycle, and electron transport.
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T cells will switch between OXPHOS and glycolysis during an immune response.
Both naïve and memory T cells are known to favor OXPHOS as the primary metabolic
pathway of homeostasis (van der Windt et al., 2012). These metabolic differences are not
only seen between effector and non-effector T cells, but also between subsets,
particularly in the CD4+ T cells. Th1 and Th2 cells favor glycolysis, whereas Treg cells
favor OXPHOS. Th17 cells appear to utilize both glycolysis and OXPHOS. Th17 and T
reg cells even utilize different sources of fatty acids to fuel mitochondrial metabolism,
with Treg cells importing fatty acids and Th17 cells making fatty acids to use in fatty acid
oxidation (Berod et al., 2014a; Michalek et al., 2011). This difference in fatty acid
generation could be one reason for the different glycolytic states between these two
subsets.
Similar to T cells, macrophages also favor different metabolic states depending on
function. M1 macrophages utilize glycolysis when activated, which is thought to promote
the quick response these cells need for antibacterial responses. Conversely, M2
macrophages utilize OXPHOS. This is thought to help the cells maintain survival and
effector function for a much longer period, allowing these cells to better fight parasites
such as helminths (O'Neill et al., 2016; O'Neill and Pearce, 2016). Considering the
differences in metabolism between macrophage and T cell subsets, it can be appreciated
that metabolism plays an important role in the function of immune cells.
1.5 Methylation-controlled J-protein
Methylation-controlled J-protein (MCJ) is a 15-17 kDa member of the DNAJ
family of proteins encoded by the gene dnajc15 (Hatle et al., 2007; Shridhar et al., 2001).
DNAJ proteins can perform a variety of functions from protein folding to protein
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regulation. Expression of MCJ is regulated through DNA methylation, and expression is
decreased when CpG rich regions within the gene are methylated (Shridhar et al., 2001;
Strathdee et al., 2004). MCJ is highly expressed in the heart, liver, kidneys, and testis. In
the immune system, MCJ is expressed in T cells, though at a much higher level in CD8+
T cells compared to CD4+ T cells (Hatle et al., 2013). Low expression of MCJ has been
correlated with increased chemoresistance in some cancers due to excretion of the
chemotherapeutic from the cell. When MCJ is re-expressed in these cancer cells,
chemotherapeutics are retained within the cell, making the cancers chemosensitive (Hatle
et al., 2007; Shridhar et al., 2001).
1.5.1 Structure, location, and function
MCJ is a unique member of the DNAJ family of proteins. Similar to other DNAJ
family members, MCJ contains a DNAJ domain, though it is located at the C-terminus as
opposed to the N-terminus. The N-terminus of MCJ is unique among the DNAJ family
members. MCJ also contains a transmembrane domain, unlike many DNAJ family
members (Hatle et al., 2013; Hatle et al., 2007).
MCJ is located in mitochondria, and the transmembrane domain allows the
protein to associate with the inner mitochondrial membrane (Hatle et al., 2013) where
MCJ performs its function as a regulator of mitochondrial metabolism. MCJ associates
with complex I of the electron transport chain (Hatle et al., 2013) and reduces electron
flow through the electron transport chain (ETC) by reducing both complex I activity and
supercomplex formation (Hatle et al., 2013). Supercomplexes are associations of
complexes I, III, and IV of the ETC. These supercomplexes can have a variety of
combinations (e.g. supercomplex I/III/IV or supercomplex I/III) and can even contain
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multiples of a complex (e.g. supercomplex I/III2/IV, where the subscript denotes the
number of a given complex) (Vartak et al., 2013). MCJ was found to reduce
supercomplex formation, which is thought to reduce the efficiency and rate of electron
flow through the ETC (Hatle et al., 2013).
1.5.2 Role in the immune system
Studies on the role of MCJ in the immune system have been carried out primarily
through the use of mice deficient in MCJ (Hatle et al., 2013). As a negative regulator of
complex I, it was not surprising that the loss of MCJ in CD8+ T cells resulted in an
increase in oxygen consumption in mitochondria, increased ATP production, and an
accumulation of amino acids (Champagne et al., 2016). MCJ-deficiency increased
cytokine secretion in activated CD8+ T cells. Loss of MCJ. Loss of MCJ in CD8+ T cells
had no effect on cell proliferation or death immediately after activation in vitro, but did
allow activated effector T cells to survive after cytokine withdrawal, which is one
mediator of apoptotic death (Champagne et al., 2016; Snow et al., 2010). The ability to
withstand cytokine withdrawal could potentially explain the fact that MCJ deficient CD8+
T cells have an increased memory response to viral infection (Champagne et al., 2016).
While it is apparent that MCJ affects the metabolism and memory function of T cells, it is
not clear why the loss of MCJ promotes the survival of CD8+ T cells.
1.6 Cell Death
Cell death is an important process in all animals. It plays a key role in many
aspects of biology, from embryo development to tissue homeostasis and even immune
responses. For the immune system, cell death is critical during T cell development. In the
thymus, autoreactive T cells undergo death to eliminate autoreactive T cells. In addition,
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following an immune response, effector T cells that have proliferated need to die to
prevent unintentional tissue damage. The timely death of effector T cells is possible due
to a dramatic increase in susceptibility to death signals once the cell is activated (Green et
al., 2003; Snow et al., 2010). Emerging evidence suggests that the increased sensitivity is
linked to the upregulation of glycolysis after T cell activation, though the full mechanism
of how glycolysis increases sensitivity to death signals is not well understood (Larsen et
al., 2017). Defects in T cell death can lead to lymphomas as well as autoimmune disease,
so a better understanding of how susceptibility to cell death is regulated in T cells is
critical for finding therapeutic interventions for these diseases.
1.6.1 Forms of cell death
There are many ways for a cell to die. Cell death can be split into two general
categories; necrosis versus apoptosis. Necrotic death occurs through rupture of the
cytoplasmic membrane and is highly inflammatory. Apoptosis occurs through a
mechanism initiated by the cell itself or externally by death ligands such as TNF, FasLigand, or TRAIL. and as such, is often called programmed cell death (Tait et al., 2014).
Apoptotic cell death can take many forms, and each one utilizes a unique pathway in the
cell. Some of those pathways utilize caspases whereas others do not.
One caspase-independent pathway is necroptosis, which begins with the
stimulation of a death receptor ligand such as TNF (Degterev et al., 2005). When
caspase-8 is inhibited, either chemically or by interaction with an inhibitory protein,
receptor-interacting serine/threonine-protein kinase (RIPK) 1 and 3 will interact at the
death receptor and become activated. RIPK3 then phosphorylates mixed-lineage kinase
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domain-like (MLKL), which oligomerizes and forms pores in the plasma membrane,
leading to necrotic cell death (Murphy et al., 2013; Tait et al., 2014).
Ferroptosis is an iron-dependent form of caspase-independent cell death.
Originally identified through the use of the small molecule erastin, ferroptosis results
from the inhibition of the glutamate/cystine transporter. This leads to antioxidant
starvation through the loss of glutathione. The decrease in antioxidants causes an increase
in oxidative stress and lipid peroxidation, which ultimately induces cell death (Dixon et
al., 2012; Gao et al., 2018).
Autophagic cell death has been documented in various eukaryotes such as slime
molds and fruit flies but has not been fully appreciated in vivo in mammals. When studied
in vitro, autophagic cell death is dependent on autophagic proteins such as Beclin-1,
ATG5, and ATG7. The autophagy pathway can be initiated when other routes of cell
death are inhibited, such as through the inhibition of capsase-8 or with the loss of BAX
and BAK (Shimizu et al., 2004; Yu et al., 2004). As autophagy is initiated, ROS and
oxidative stress will increase in the cell, partly due to the degradation of catalase, and
induce cell death (Yu et al., 2006).
Unlike the previously summarized forms of cell death, pyroptosis is induced by
caspases. Caspase-1 and caspase-11 (in mouse) are inflammatory caspases that are
responsible for processing and activating the cytokines IL-1β and IL-18. During
pyroptosis, DNA is fragmented, and the cell will swell and lyse. It is not completely
understood why pyroptosis occurs. One reason could be to increase the release of IL-1β
and IL-18. This process is pro-inflammatory and helps control bacterial infections
(Bergsbaken et al., 2009; Tait et al., 2014).
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1.6.2 Apoptosis and caspases
First defined in 1972 (Kerr et al., 1972), apoptosis is the form of death that cells
undergo during tissue development, and post-development tissue homeostasis. The term
“apoptosis” is Greek meaning “falling off” and refers to the way in which flower petals
or leaves fall off a flower or tree. The “falling off” that happens in cell death is the
blebbing of small membrane-bound compartments, known as apoptotic bodies, from a
cell undergoing apoptosis. Apoptosis begins with the condensation of nuclear chromatin
and fragmentation of DNA, which results in the engulfment and degradation of apoptotic
bodies by phagocytic cells (Kerr et al., 1972).
Apoptosis is mediated by proteases called caspases (cysteine-containing
aspartate-cleaving proteases). Cleavage of caspases can be done by Caspases involved in
apoptosis can be sorted into two major groups, upstream initiator caspases that respond to
death stimuli, and downstream effector caspases that carry out the destruction of the cell.
Caspases are translated as zymogens, meaning they need to be cleaved to become active.
Cleavage of caspases is usually done by upstream caspases. In the case of apoptosis,
effector caspases are cleaved by initiator caspases. Those initiator caspases can be
activated by other initiator caspases, or they can be activated through a process called
proximity induced autoactivation (Fig. 1.5). In this method of activation, the inactive
zymogen has an intrinsic activity and will autocleave when in close proximity to other
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caspase zymogens. This is the mechanism through which caspase-8 is activated, initiating
the extrinsic pathway of apoptosis (Muzio et al., 1998).

Figure 1.5: Models of caspase activation
Through the extrinsic pathway of apoptosis, an extracellular signal is transduced
across the cellular membrane to activate caspases and induce apoptosis (Fig 1.6). This
signal transduction begins with the ligation of a death receptor (e.g. Fas, TNFR,
TRAILR) with its ligand, which results in oligomerization of the receptor. The death
receptors contain a cytosolic death domain (DD), which will form a homodimer with the
DD of the adapter protein Fas-associated death domain protein (FADD) (Boldin et al.,
1995; Chinnaiyan et al., 1995). FADD then recruits pro-caspase-8 or pro-caspase-10
through dimerization of a death effector domain (DED) found on both FADD and certain
36

caspases. Recruitment of caspases-8 or -10 through DED interactions forms the deathinducing signaling complex (DISC) (Kischkel et al., 1995; Muzio et al., 1996). The
caspases in the DISC become active and cleave pro-caspase-3 and/or pro-caspase-7 to
activate the caspases, which then go on to induce apoptosis. The DISC can also result in
the activation of the cell intrinsic pathway of apoptosis through the cleavage of BID to
form active pro-apoptotic tBID (Luo et al., 1998).

Figure 1.6: Extrinsic initiation of apoptosis
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In the intrinsic pathway of apoptosis, the release of cytochrome c from the
mitochondria results in the activation of the caspase cascade. This process begins with the
activation or expression of pro-apoptotic molecules, such as PUMA, BID, or BAD, as a
result of cell stress or damage (Kuwana et al., 2005; Leibowitz and Yu, 2010). The
presence or activation of these molecules triggers the activation of BAX and/or BAK,
which form pores in the outer membrane of the mitochondria (Gross et al., 1999).
Cytochrome c is then released and binds to Apaf-1, forming a complex that can recruit
pro-caspase-9 through a caspase recruitment domain (CARD) found on both Apaf-1 and
caspase-9. Once bound to the complex, known as the apoptosome, pro-caspase-9
becomes active, then cleaves and activates pro-caspase-3 and pro-caspase-7 (Li et al.,
1997; Srinivasula et al., 1998).
As proteases, the way in which effector caspases execute apoptosis is through the
cleavage of critical proteins. Caspases can cleave proteins, at particular aspartate
residues, important in maintaining the cytoskeleton, such as actin, myosin, and filamin
(Browne et al., 2000; Taylor et al., 2008). While cleavage of the cytoskeleton helps to
weaken the structural integrity of the cell, the blebbing of the membrane is due to the
cleavage of a protein called ROCK1, a kinase that increases myosin contraction of actin
filaments through phosphorylation. Cleavage of ROCK1 by caspases results in a
truncated form of ROCK1 that has increased kinase activity, resulting in the blebbing of
portions of the cell that have been structurally weakened through the degradation of the
cytoskeleton (Coleman et al., 2001).
ROCK1 has also been implicated in another hallmark of apoptosis, the
fragmentation of the nuclear envelope. Similar to cell membrane blebbing, ROCK1
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facilitates the tearing of the nuclear membrane by increasing the activity of myosin (Croft
et al., 2005). This causes the actin filaments attached to the nuclear envelope to contract
and pull the envelope apart. This also requires weakening of the nuclear envelope, which
happens through the cleavage of nuclear lamins by caspases (Orth et al., 1996; Rao et al.,
1996).
Within the nucleus, DNA also undergoes fragmentation due to caspase-3 cleavage
of the inhibitor of caspase-activated DNase (ICAD), which is found heterodimerized with
caspase-activated DNase (CAD). Once liberated from ICAD, CAD fragments nuclear
DNA (Liu et al., 1997; Taylor et al., 2008), which is important to prevent the activation
of the innate immune system and autoinflammatory disease (Kawane et al., 2003; Napirei
et al., 2000).
In addition to the nuclear degradation, the Golgi apparatus, ER, and mitochondria
are fragmented during apoptosis. While the fragmentation of the Golgi and ER are
dependent on caspases, mitochondrial degradation is due to the disruption of the
mitochondrial membrane by BAX and BAK (Taylor et al., 2008). Ultimately, the
fragmentation of these organelles, along with the proteolysis of the cytoskeleton and
blebbing of the membrane, allow the apoptotic cell to break into smaller apoptotic bodies
that can be engulfed by phagocytes.
Since the intracellular components of the dying cell are contained within the
apoptotic bodies, apoptosis is considered a non-inflammatory form of cell death. In fact,
phagocytes have been shown to release anti-inflammatory molecules (IL-10, TGF-β), and
reduce the production of pro-inflammatory molecules (IL-12, IL-1β, TNF-α) upon
phagocytosis of apoptotic bodies (Fadok et al., 1998; Kim et al., 2004; Nagata, 2018).
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Efferocytosis, or the phagocytosis of apoptotic bodies, is potentially so important for the
regulation of the immune system during tissue homeostasis that dysregulation of this
process has been suggested to induce autoimmune diseases such as systemic lupus
erythematosus (SLE) (Hanayama et al., 2004; Nagata et al., 2010; Ravichandran, 2010).
Recent evidence suggests efferocytosis is a specialized type of phagocytosis called LC3associated phagocytosis, which recruits autophagy machinery to complete the
phagocytosis of apoptotic bodies (Martinez et al., 2016).
1.6.3 Anti-apoptotic and pro-apoptotic molecules
Mitochondria play an important part of the intrinsic apoptotic pathway. The
release of cytochrome c from mitochondria contributes to the formation of the
Apoptosome, which also includes caspase-9 and ATP. This leads to activation of
downstream effector caspases and cell death. Due to the implications of mitochondrial
integrity in cell death, there are many proteins in the cell involved in preventing or
promoting death through mitochondrial disruption. These proteins are members of the Bcell lymphoma-2 (BCL-2) family of proteins.
BCL-2 proteins can be divided into two categories: anti-apoptotic and proapoptotic. All members of the BCL-2 family contain at least one BCL-2 homology (BH)
domain. The anti-apoptotic proteins contain four BH domains, while the pro-apoptotic
proteins contain three BH domains (Leibowitz and Yu, 2010; Taylor et al., 2008).
The BCL-2 family functions by interacting with each other to prevent or promote
cell death. The BCL-2 pro-apoptotic proteins, specifically BAX and BAK, form pores in
the mitochondrial membrane allowing the release of cytochrome c, as well as
Smac/DIABLO, which blocks the function of inhibitors of apoptosis (IAPs). The BCL-2
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anti-apoptotic members, such as BCL-2, MCL-1, and BCL-xL, primarily function by
preventing the formation of BAX/BAK pores the outer mitochondrial membrane. This
can happen through the direct interaction with BAX/BAK, or by binding to BH3-only
proteins that can promote BAX/BAK oligomerization (Antonsson and Martinou, 2000;
Leibowitz and Yu, 2010; Taylor et al., 2008).
Members of the BCL-2 family are not the only proteins that are involved in
apoptosis. Some proteins induce apoptosis by activating caspases, such as apoptotic
protease activating factor 1 (Apaf-1), which promotes the activation of caspase-9 (Li et
al., 1997; Srinivasula et al., 1998). Others prevent apoptosis by binding to pro-apoptotic
proteins, such as ICAD which binds to CAD to prevent DNA fragmentation (Liu et al.,
1997; Taylor et al., 2008). Apaf-1 and ICAD, along with many other pro- and antiapoptotic proteins, either activate or are cleaved by caspases.
1.6.4 Non-death functions of caspases
Caspases are known as inducers of cell death, but some caspases have functions
that are not related to cell death. For instance, caspase-3 is important for the
differentiation of skeletal muscle as it is required for the cleavage and activation of
mammalian sterile twenty-like kinase, which is critical in the differentiation process
(Fernando et al., 2002). Caspase-3 also helps to negatively regulate B cell cycling by
cleaving p21, which can increase cycling in B cells (Woo et al., 2003). Some caspases
were even discovered for their non-death functions. Caspase-1 was initially discovered as
a protease that cleaves pro-IL-1 into the proinflammatory cytokine IL-1β and caspase-11
was found to be involved in the processing of another proinflammatory cytokine, IL-18

41

(Black et al., 1989; Viganò and Mortellaro, 2013; Wang et al., 1996). While both
caspases can induce death via pyroptosis, cytokine processing is their canonical function.
Caspase-8 is needed to transduce death signals through death receptors. However,
caspase-8 is also necessary for the proliferation in T cells upon TCR stimulation (Misra et
al., 2007). This makes caspase-8 interesting because these two opposing functions are
dependent upon the location of caspase-8 in the cell. During activation and T cell
proliferation, caspase-8 is located in lipid rafts at the plasma membrane. When Fas is
stimulated to induce cell death, caspase-8 is found in the cytosol of the cell (Koenig et al.,
2008). The location of the caspase is just as important as its activation state when
considering the function of the enzyme.
1.6.5 Posttranslational regulation of caspases
Posttranslational modifications are changes made to proteins after they are
synthesized and can range from cleavage to the addition of a small molecule to an amino
acid. Some posttranslational modifications, such as phosphorylation, can change the
function of the protein, while others will lead to the destruction of the protein (i.e.
polyubiquitylation). Caspases normally undergo at least one posttranslational
modification, which is the cleavage or the protein into an active state. Other
posttranslational modifications have been reported for caspases, specifically caspase-3.
Since caspases have a cysteine that functions as the proteolytic residue of the enzyme,
any modification of that cysteine can inactivate the caspase. Cysteines are particularly
sensitive to redox-dependent posttranslational modifications, such as s-nitrosylation and
glutathionylation. Caspase-3 has been shown to be inactivated by both s-nitrosylation and
glutathionylation, and s-nitrosylation of caspase-3 was reported to be important for
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maintaining T cell survival in the presence of IL-15 (Huang et al., 2008b; Mannick, 2007;
Mitchell et al., 2007; Saligrama et al., 2014).
1.7 Glutathionylation
Oxidative stress caused by reactive oxygen species (ROS) can induce a variety of
deleterious aberrations in cells, such as irreversible protein damage, DNA damage, lipid
peroxidation, and cell death (Perl, 2013). Cells have several antioxidant mechanisms
through which they can reduce oxidative stress. One of the most important of these
mechanisms is the use of glutathione (γ-glutamyl-cysteinyl-glycine). This tripeptide
exists in both the reduced (GSH) and oxidized (GSSG) state and can be converted
between the two states by glutathione reductase or thioredoxin and thioredoxin reductase
(Deponte, 2013). Glutathione has two main functions in reducing oxidative stress. It can
function as an antioxidant by reducing ROS and forming GSSG, and by protecting
proteins from over-oxidation (Popov, 2014).
Thiols (R-SH), often those found on cysteines, are very sensitive to oxidative
stress. Due to this sensitivity, the cell will add glutathione to the thiol to protect it from
irreversible oxidation. Glutathionylation is mediated by glutathione S-transferases and
deglutathionylation is mediated by glutaredoxin, thioredoxin, and sulfiredoxin (Tew and
Townsend, 2012). Thiols can be modified when in a reduced state (-SH) or a mildly
oxidized sulfenyl state (-SOH) (Giustarini et al., 2004). The result of protein
glutathionylation is a protein modified with a glutathione moiety, which can be actively
removed by the cell.
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1.7.1 Synthesis of glutathione
Glutathione is composed of three amino acids: glutamate, cysteine, and glycine.
The first step in the synthesis of glutathione is to ligate glutamate and cysteine. This is
done by glutamate-cysteine ligase and requires one ATP molecule. This step is also ratelimiting due to the low concentration of cysteine in the cell (Lu, 2013). The second and
last step of glutathione synthesis is the addition of glycine by GSH synthase and results in
the formation of GSH (Lu, 2013).
1.7.2 Modification of proteins
Protein S-glutathionylation serves to both protect proteins from irreversible
oxidation and to regulate protein function. Glutathione can be added and removed from
proteins by enzymes, making the modification reversible. Protein glutathionylation can
change the function of proteins and if the modified cysteine is involved in the activity of
an enzyme, then the modification may result in inactivation (Giustarini et al., 2004).
These modifications typically happen when a cell is under oxidative stress. In T cells,
GAPDH is known to be glutathionylated and its activity is reduced when the cell is under
oxidative stress (Ghezzi et al., 2002). Previous studies have shown that the oxidative state
of T cells can change depending on the environment they are in and this oxidative state
can influence T cell survival (Saligrama et al., 2014). However, further studies are
needed to fully understand how the environment can affect protein glutathionylation in T
cells, which proteins are glutathionylated, and how changing the function of those
proteins impacts the cell.
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1.8 Dissertation Aims
The metabolic state of immune cells is highly important in determining their
function and fate. Varying the balance of oxidative phosphorylation and glycolysis allows
a cell to perform different functions, which is exemplified by CD4+ T cell subsets (Berod
et al., 2014b; Michalek et al., 2011; Pearce and Pearce, 2013). CD8+ T cells are known to
utilize glycolysis during activation, and oxidative phosphorylation in the memory state
(Roos and Loos, 1973a; van der Windt et al., 2012), though it is not known how
metabolism influences the contraction that leads to memory. The work presented in the
following chapters of this dissertation aims to answer two important questions related to
T cell metabolism during proliferation and death:
1. Does metabolism regulate caspase activity in effector T cells?
2. Are T cell proliferation and contraction linked?
The answers to these questions will fill the gaps in knowledge of how deeply metabolism
is integrated into the resolution of the immune response and how the immune system is
able to mitigate the autoimmune risk associated with the rapid proliferation of effector
immune cells.
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CHAPTER 2: GLYCOLYSIS PROMOTES CASPASE-3 ACTIVATION IN LIPID
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2.1 Abstract
Resting T cells undergo a rapid metabolic shift to glycolysis upon activation in
the presence of IL-2, in contrast to oxidative mitochondrial respiration with IL-15.
Paralleling these different metabolic states are striking differences in susceptibility to
restimulation induced cell death (RICD); glycolytic effector T cells are highly sensitive to
RICD whereas non-glycolytic T cells are resistant. It is unclear whether the metabolic
state of a T cell is linked to its susceptibility to RICD. Our findings reveal that IL-2driven glycolysis promotes caspase-3 activity and increases sensitivity to RICD. Neither
caspase-7, caspase-8, nor caspase-9 activity is affected by these metabolic differences.
Inhibition of glycolysis with 2-deoxyglucose reduces caspase-3 activity as well as
sensitivity to RICD. By contrast, IL-15-driven oxidative phosphorylation actively inhibits
caspase-3 activity through its glutathionylation. We further observe active caspase-3 in
the lipid rafts of glycolytic but not non-glycolytic T cells, suggesting a proximity-induced
model of self-activation. Finally, we observe that effector T cells during influenza
infection manifest higher levels of active caspase-3 than naïve T cells. Collectively, our
findings demonstrate that glycolysis drives caspase-3 activity and susceptibility to cell
death in effector T cells independently of upstream caspases. Linking metabolism,
caspase-3 activity, and cell death provides an intrinsic mechanism for T cells to limit the
duration of effector function.
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2.2 Introduction
The balance of cell proliferation and cell death is critical for the maintenance of
stable cell numbers and tissue homeostasis. Thus, it is perhaps not surprising that these
opposing processes may be mechanistically linked in various cell types, including cancer
(Evan et al., 1994; Wang et al., 2011). During an immune response, T lymphocytes
undergo a period of very rapid proliferation. During this expansion, T cells also become
susceptible to T cell receptor (TCR) restimulation-induced cell death (RICD) (Green et
al., 2003; Snow et al., 2010). However, the link between proliferation and susceptibility
to death remains poorly understood (Hedrick et al., 2010).
Changes in cellular metabolism are well recognized to play a critical role during
an effective immune response. Resting naïve T lymphocytes, upon activation, undergo a
dramatic metabolic shift from oxidative phosphorylation to aerobic glycolysis (Hume et
al., 1978; Roos and Loos, 1973a; Roos and Loos, 1973b). The switch to a largely
glycolytic state allows the cell to generate the synthetic capacity needed for rapid
proliferation and effector function, such as cytokine production. In a similar manner, B
cells and dendritic cells also utilize glycolysis upon activation to enable their effector
functions (Santambrogio et al., 2005; Woo et al., 2003). Recent studies have further
indicated that the metabolic state of effector T cells helps determine their subset
differentiation (Michalek et al., 2011). Differing metabolic states are also known to be
involved in the specification of T cell memory, with central memory T cells exhibiting
high oxidative phosphorylation and effector memory T cells being more glycolytic
(O'Sullivan et al., 2014; Phan et al., 2016; van der Windt et al., 2012).
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It is well appreciated that cell death and metabolism are closely linked. Glycolytic
enzymes can be induced by the same transcription factors that upregulate the expression
of anti-apoptotic proteins such as BCL-xL (Green et al., 2014). Other proteins with
metabolic function, such as cytochrome c, are directly involved in cell death (Green et al.,
2014; Mason and Rathmell, 2011). When released from the mitochondria, cytochrome c
activates caspase-9, which then cleaves caspase-3 and induces apoptosis. Caspase-3 can
be alternatively activated through cleavage by caspase-8, which is activated by death
receptors such as Fas (CD95). However, little is known regarding possible links between
metabolism and caspase activity.
Though caspases were originally defined for their role in cell death, it is now
appreciated that caspases perform many functions in cells in addition to cell death
(Lamkanfi et al., 2007; Shalini et al., 2015). This is particularly well established for
caspase-8, an initiator caspase that can induce apoptosis upon ligation of a death receptor
(Medema et al., 1997), but can also allow cell proliferation by inhibiting formation of the
necroptosome and induction of necroptosis (Dillon et al., 2012). Active caspase-3, a
critical downstream mediator of apoptosis, has also been observed in non-dying cells and
is implicated in skeletal muscle differentiation (Fernando et al., 2002), T cell anergy
(Puga et al., 2008), B cell cycling (Woo et al., 2003), and erythrocyte maturation
(Lamkanfi et al., 2007). However, these studies did not examine how caspase-3 activity is
being regulated in these non-apoptotic situations. Moreover, an explanation has been
lacking for the molecular switch between TCR-stimulated proliferation of naïve T cells
versus induction of cell death in effector T cells (Green et al., 2003; Snow et al., 2010).
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Given the involvement of caspases in both cell death and non-death functions,
regulation of caspase activity and its location in cells are of paramount importance in
determining cell fate. We have observed that T cells grown in interleukin (IL)-2 versus
IL-15 have similar amounts of total pro-caspase-3, but IL-2-cultured T cells have a
substantially higher level of active caspase-3, and as a result are much more susceptible
to RICD (Saligrama et al., 2014). IL-15-cultured T cells are resistant to this form of cell
death, in part due to the high levels of reactive oxygen and nitrogen species that lead to
the redox modification of a critical cysteine in the active site of caspase-3, resulting in its
inactivation (Huang et al., 2008a; Mitchell and Marletta, 2005a; Saligrama et al., 2014).
IL-2 and IL-15 also induce very different metabolic states in T cells; IL-2 promotes
glycolysis, whereas IL-15 upregulates oxidative phosphorylation (van der Windt et al.,
2012). We now observe that caspase-3 activity in non-dying effector T cells is largely a
function of their glycolytic state. Inhibition of glycolysis by a variety of methods reduces
caspase-3 activity and protects T cells from RICD. In addition, IL-15-cultured T cells
further reduce caspase-3 activity through its inactivation by glutathionylation. These
findings underscore the importance of cellular metabolism in the regulation of caspase-3
activity and susceptibility toward cell death.
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2.3 Results
2.3.1 IL-15 induces mitochondrial ROS and glutathionylation of caspase-3
To investigate the influence of cell metabolism on caspase activity, we initially
modeled two metabolic states in vitro using cytokines that are known to promote very
different levels of glycolysis following T cell activation: IL-2, which upregulates
glycolysis, and IL-15, known to induce a non-glycolytic state of mitochondrial
respiration (van der Windt et al., 2012). To mimic an immune response in vitro, purified
naïve T cells were activated with anti-CD3/CD28 in the presence of IL-2 for 2 days, then
removed from stimulation and propagated in IL-2 for an additional day. The activated T
cells were then washed thoroughly to remove exogenous cytokines and recultured in
medium containing either IL-2 or IL-15 for an additional 3 days. In agreement with
previous observations (van der Windt et al., 2012), IL-15-cultured T cells manifested
high mitochondrial respiration, as reflected by a high oxygen consumption rate (OCR)
(Fig. 2.1A). Consistent with these findings, complex I activity of the electron transport
chain was higher in IL-15-cultured T cells than in IL-2-cultured T cells (Fig. 2.1B and C).
Complex I is known to generate reactive oxygen species (ROS) (Grivennikova and
Vinogradov, 2006), and we determined that IL-15 induced a greater amount of
mitochondrial ROS compared to IL-2 (Fig. 2.1D) as measured using the mitochondriatargeted probe mitoboronic acid (MitoB) (Cochemé et al., 2011). MitoB is converted to
mitophenol (MitoP) upon reaction with mitochondrial hydrogen peroxide, and the levels
of MitoB and MitoP are then measured by liquid chromatography tandem mass
spectrometry and expressed as a ratio of MitoP to MitoB (Cochemé et al., 2011).
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ROS can promote protein glutathionylation, a process that results in the reversible
modification of a cysteine by glutathione (Giustarini et al., 2004). Caspase-3 has been
shown previously to be inactivated in HL-60 cells by the glutathionylation of the critical
cysteine in the enzymatic pocket (Huang et al., 2008a). We therefore investigated the
possibility that caspase-3 is glutathionylated in IL-15-cultured T cells. Glutathionylated
proteins were immunoprecipitated and immunoblotted for caspase-3 (Fig. 2.2A).
Caspase-3 was glutathionylated to a considerably greater extent in the IL-15-cultured T
cells compared to IL-2 (Fig. 2.2B). Of interest, the glutathionylation was observed
specifically on cleaved caspase-3 (Fig. 2.2A). This implies that full-length pro-caspase-3
was initially cleaved and then inactivated by glutathionylation.
Given that IL-15 induced a greater amount of mitochondrial ROS compared to IL2 (Fig. 2.1D), we examined the effect of quenching mitochondrial ROS on overall
caspase activity in activated T cells. IL-2- and IL-15-cultured T cells were incubated with
the mitochondria-targeted antioxidant mitoquinone (MitoQ) to quench mitochondrial
ROS (Kelso et al., 2001). MitoQ treatment of IL-15-cultured T cells, but not IL-2cultured T cells, induced a reduction in ROS (Fig. 2.2C). The lack of effect of MitoQ in
IL-2-cultured T cells may reflect a non-mitochondrial source of ROS, such as
cytoplasmic NADPH oxidases. Consistent with these findings, MitoQ did not alter
caspase activity in IL-2-cultured T cells, but did slightly increase caspase activity in IL15-cultured T cells, though not to the level of caspase activity in IL-2-cultured T cells
(Fig. 2.2D). Consistent with these findings, treatment with MitoQ did not affect the
sensitivity of IL-2- or IL-15-cultured T cells to death, either before or after restimulation
(Fig. 2.2E). Thus, mitochondrially-derived ROS partially contributed to the low level of
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caspase activity in IL-15-cultured T cells, but were not solely responsible for the
decreased sensitivity to RICD. We therefore considered that the pronounced metabolic
shift to glycolysis during T cell activation might also influence the activity of certain
caspases and sensitivity to RICD.
2.3.2 Glycolysis drives caspase-3 activation
Glycolysis was measured by extracellular acidification rate (ECAR) in naïve T
cells, effector T cells (day 6 after activation), and late effector T cells (day 10 after
activation). Glycolysis increased initially from naïve to day 6 T cells, then decreased
from day 6 to day 10 (Fig. 2.3A). These changes were greater in the IL-2-cultured T cells
than IL-15. IL-2 signaling is known to drive glycolysis (van der Windt et al., 2012), and
the kinetics of glycolysis in T cells grown in IL-2 closely paralleled the levels of surface
IL-2 receptor α (CD25) expression, which also peaked and declined over a nearly
identical time span (Fig. 2.3B). These results are consistent with previously reported
kinetics of CD25 expression (Cantrell and Smith, 1983). Concomitant with the rise of
glycolysis and surface CD25 expression following T cell activation, we observed an
increase in total caspase activity. T cells propagated in IL-2 continued to increase caspase
activity until a peak at day 6, after which it declined through day 10, closely paralleling
ECAR and CD25 expression (Fig. 2.3C). As a result of the culturing system and the
introduction of IL-15 at day 3, the first measurements of caspase activity and CD25
expression occurred on day 4 for IL-15-cultured T cells. In the presence of IL-15, CD25
expression and caspase activity remained at a consistently low level throughout the same
10-day period (Fig. 2.3C). The largest difference in caspase activity between IL-2- and
IL-15-cultured T cells was at day 6. We also measured the level of active caspase-3 by
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flow cytometry, and found it to be greater in IL-2-cultured T cells compared with IL-15cultured T cells at day 6 (Fig. 2.3D). Whereas caspase-3 activity was detected in live IL2-cultured T cells, activity was much higher in cells in which death was induced through
Fas stimulation (Fig. 2.3D). Thus, the intermediate levels of active caspase-3 in
proliferating T cells were not due to contaminating dead cells, but rather were present in
all IL-2-cultured T cells.
To extend the observed correlation of glycolysis with caspase activity, we
examined CD4+ T cell functional subsets, which have been shown to have varying levels
of glycolytic activity (Michalek et al., 2011). In vitro-differentiated T helper (Th)1 and
Th2 cells were reported to have high levels of glycolysis, being slightly higher in Th2
cells. By contrast, in vitro-differentiated T regulatory (Treg) cells had low levels of
glycolysis. Purified naïve CD4+ T cells were differentiated into Th1, Th2, and Treg cells
in vitro and their caspase activity was measured. Caspase activity was highest in the Th2
subset and lowest in the Treg subset, matching glycolytic activity (Fig. 2.3E and F).
These collective findings suggested that glycolysis and caspase activity might be
causally linked. We thus examined more directly the effect of glycolysis on caspase
activity. To inhibit glycolysis, IL-2-cultured T cells were incubated with 2-deoxy-Dglucose (2-DG), a glucose analog that blocks glucose catabolism after phosphorylation by
hexokinase (Wick et al., 1957). As an inhibitor of glycolysis, 2-DG could potentially
induce cell death in highly glycolytic IL-2-cultured T cells. To reduce contamination by
dead cells, the 2-DG cell cultures were centrifuged over Histopaque. The inhibition of
glycolysis by 2-DG was confirmed by measuring a decrease in ECAR (Fig. 2.4A). In
parallel, caspase activity was also decreased, in a dose-dependent manner, in IL-270

cultured T cells cultured with 2-DG (Fig. 2.4B). To confirm that the decrease in caspase
activity was due to the inhibition of glycolysis and not an off-target effect of 2-DG, we
also inhibited glycolysis by two other methods, culturing IL-2-cultured T cells with
rapamycin or in a low-glucose medium. These treatments also reduced caspase activity in
IL-2-cultured T cells (Fig. 2.4B) but not in IL-15-cultured T cells (Fig. 2.4C).
To determine whether the regulation of caspase activity by glycolysis was
selective for certain caspases, we examined the levels of specific caspase activity in IL-2cultured T cells in the presence or absence of 2-DG, using biotin-VAD (bVAD) to
selectively precipitate only active caspases with streptavidin-coated Sepharose beads.
Immunoblot analysis of the precipitates revealed that 2-DG caused a profound decrease
in caspase-3 activity, but had no effect on the activities of the related effector caspase-7,
nor the upstream caspase-8 or caspase-9 (Fig. 2.5A and B). The disparate levels of active
caspase-3 in glycolytic versus non-glycolytic T cells suggested they might differ in their
susceptibility to cell death following TCR restimulation. Day 6 IL-2-cultured T cells
cultured with and without 2-DG were restimulated with anti-CD3. While 2-DG induced
more cell death prior to restimulation (Fig. 2.5C), the 2-DG-treated cells were
considerably more resistant to restimulation-induced cell death (RICD) (Fig. 2.5D).
RICD is primarily mediated by Fas-ligand (FasL) signaling (Alderson et al., 1995).
Therefore, we measured FasL by western blot and found expression to be highest in
glycolytic IL-2-cultured T cells, and slightly less in non-glycolytic IL-15-cultured and 2DG-treated T cells (Fig. 2.5E and F). However, the fact that the activities of caspases-8
and -9 were not affected by 2-DG suggests that FasL did not mediate caspase-3 activity
in viable IL-2-cultured T cells.
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2.3.3 Active caspase-3 is sequestered in membrane lipid rafts in effector T cells
Self-cleavage of caspases can occur when pro-caspases are clustered in close
proximity (Muzio et al., 1998), such as in lipid rafts where caspase-8 is known to be
active in effector T cells (Koenig et al., 2008; Misra et al., 2007). To determine if
caspase-3 was localized to membrane lipid rafts in effector T cells, lipid rafts were
purified from both glycolytic, IL-2-cultured T cells, and non-glycolytic, IL-15-cultured T
cells and the resulting fractions were analyzed for caspase-3 cleavage and activity. In IL2-cultured glycolytic T cells, pro-caspase-3 was present primarily in the non-raft
fractions, and to a much lesser extent in the raft fractions (Fig. 2.6A, raft fractions: 3-5;
non-raft fractions: 10 and 11). However, caspase-3 was extensively cleaved only in the
lipid raft fractions. In the IL-15-cultured non-glycolytic T cells, pro-caspase-3 was also
found predominantly in the non-raft fractions. Although caspase-3 was also observed to
be cleaved primarily in the raft fractions of IL-15-cultured T cells, it was to a lesser
extent than in IL-2-cultured T cells (Fig. 2.6B). Hence the ratio of cleaved caspase-3 to
pro-caspase-3 was greater in the lipid rafts of IL-2-cultured glycolytic T cells than in nonglycolytic IL-15-cultured T cells (Fig. 2.6C).
To confirm that the cleaved caspase-3 observed in lipid rafts was active, we
performed a bVAD precipitation on the lipid raft fractions 3-5 and the non-raft fraction
11. Caspase-3 was found to be active at a much greater extent in the raft fractions of IL2-cultured glycolytic T cells, compared with IL-15-cultured non-glycolytic T cells (Fig.
2.6D and E).
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2.3.4 Caspase-3 activity increases in effector T cells during influenza infection
To determine whether active caspase-3 is observed in activated T cells in vivo,
mice were infected intranasally with influenza virus strain A/Puerto Rico/8/1934 H1N1
(Flu) and lymphocytes from the lung-draining mediastinal lymph node were analyzed
after 6 days. Caspase-3 activity was measured in naïve (CD44low) and proliferating
effector (CD44high) CD4+ and CD8+ T cells (Fig. 2.7A). The percentage of active caspase3-positive cells, as well as the median fluorescence intensity (MFI) of active caspase-3
staining, were increased in the CD44high population of both CD4+ and CD8+ T cells after
Flu infection, compared to the CD44low population (Fig. 2.7B).
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2.4 Discussion
The present findings reveal that IL-2-mediated glycolysis increases caspase-3
activity and the consequential susceptibility of effector T cells to caspase-3-mediated cell
death. IL-15, by contrast, drives low levels of glycolysis that favor low caspase-3
activity. The high amount of oxidative metabolism in IL-15-cultured T cells also
promotes a further decrease in caspase-3 activity through its glutathionylation. Our data
support a model by which glycolytic metabolism sets the stage for a high proliferative
rate of effector T cells that is coupled to enhanced susceptibility to death cues through the
activity of downstream effector caspase-3.
Cleavage of caspase-3 can be induced by upstream caspase-8 following Fas
ligation, and by caspase-9 following cytochrome c release from the mitochondria. It is
also possible for cleavage of caspase-3 to occur by self-activation when caspase-3
molecules are clustered in close proximity (Muzio et al., 1998; Shi, 2004). We observed
that the levels of both caspase-8 and caspase-9 activity were similar between glycolytic
and non-glycolytic T cells suggesting that they are not likely to be the regulators of
caspase-3 activity in these different metabolic states. The findings are also consistent
with our previous observations that caspase-3 activity persists in effector T cells in which
caspase-8 was deleted (Koenig et al., 2014). It is possible that translocation to the cell
membrane, and particularly to lipid raft domains, allows the clustering of full-length
inactive caspase-3, and could promote its proximity-induced autocleavage and activation
(MacCorkle et al., 1998; Shi, 2004). Furthermore, while confined to lipid rafts, active
caspase-3 may also be restricted in its access to substrates that might induce cell death.
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Effector T cells and memory T cells have very different metabolic profiles.
Similar to memory T cells derived in vivo, memory-like T cells can be generated in vitro
through IL-15 signaling that promotes oxidative phosphorylation (O'Sullivan et al., 2014;
van der Windt et al., 2012). Consistent with those previous reports, we observed that
compared to IL-2, IL-15-cultured T cells have elevated oxidative phosphorylation and
mitochondrial ROS. Our findings further reveal that IL-15-cultured T cells manifest
glutathionylation of caspase-3, which is known to inactivate caspase-3 at the critical
cysteine in the enzymatic pocket (Huang et al., 2008a). Given that glutathionylation of
caspase-3 was detected only of cleaved caspase-3 in IL-15-cultured T cells, this suggests
that caspase-3 is being inactivated by glutathionylation after its cleavage. Along with our
previous report of the inactivation of caspase-3 by S-nitrosylation (Saligrama et al.,
2014), these data show that in T cells, caspase-3 can be inactivated by redox-dependent
post-translational modifications, which are influenced by the metabolic state of the cell.
Metabolically-induced modifications of apoptotic caspases may be an important
mechanism for memory T cell formation.
The correlation between glycolysis and CD25 expression for in vitro-generated
effector T cells is not surprising given the known role of IL-2 in the induction of
glycolysis in T cells. However, in vitro-differentiated T reg cells, despite expressing high
levels of CD25, are not glycolytic, likely due to their derivation with TGF (Delisle et
al., 2013; Michalek et al., 2011). We observed that these cells have low caspase activity,
indicating that caspase activity is a function of glycolysis rather than CD25 expression.
Proliferating T cells are known to be susceptible to cell death cues such as RICD
(Kabelitz and Janssen, 1997; Peter et al., 1997). Our data demonstrate independent
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increases in both FasL and caspase-3 activity in glycolytic IL-2-cultured T cells prior to
TCR restimulation. Consistent with our observations, a study recently reported that
human CD8+ T cells rapidly induced FasL protein following TCR restimulation only
when glycolytic, rendering them more susceptible to RICD (Larsen et al., 2017).
However, we do not feel that the caspase-3 activity or the capase-8 activity in
proliferating glycolytic T cells is due to Fas/FasL interactions for a few reasons. First, we
observed no increased levels of active upstream caspase-8 in IL-2-cultured T cells despite
more active caspase-3. Second, we have previously shown that Fas-deficient effector T
cells express as much active caspase-8 as wild-type T cells (Misra et al., 2007). Finally,
reducing caspase-8 activity in effector T cells by deleting its regulator, c-FLIP, had no
effect on the levels of active caspase-3 (Koenig et al., 2014). Hence, the collective
findings would indicate that the levels of active caspase-8 and caspase-3 in effector T
cells are largely independent of one another as well as independent of Fas/FasL
interactions.
At present the full spectrum of function of caspase-3 activity in viable effector T
cells is unclear. Other reports have noted a role for caspase-3 in T cell anergy (Puga et al.,
2008), cleavage of p21 and cell cycling in B cells (Woo et al., 2003), skeletal muscle
differentiation (Fernando et al., 2002), and maturation of erythrocytes, macrophages, and
dendritic cells (Lamkanfi et al., 2007). The localization of active caspase-3 in membranes
could provide access to substrates important to these functions, while simultaneously
preventing the enzyme from cleaving pro-death substrates. While it is possible that the
glycolytic state of cells may influence these other reported functions of caspase-3, the
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current findings nonetheless link metabolism to caspase-3 activity and thus provide a
plausible regulatory mechanism of immune cell homeostasis.
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2.5 Materials and Methods
Mice
C57BL/6NJ male mice (Jackson Laboratory, Bar Harbor, ME) were housed in an
Association for Assessment and Accreditation of Laboratory Animal Care Internationalapproved facility at the University of Vermont Larner College of Medicine. Mice were
used at 2-6 months of age and protocols were approved by the Institutional Animal Care
and Use Committee.
Cell Culture
T cells were purified from mouse lymph nodes (axillary, inguinal, brachial,
cervical) and spleens by negative selection as described previously (Saligrama et al.,
2014). Briefly, lymph nodes and spleens were homogenized through nylon mesh and red
blood cells were lysed with Gey’s solution. Combined lymphocytes and splenocytes were
incubated on ice for 30 min with the following antibodies: anti-CD11b (M1/70), antiMHC class II (M5/114/15/2; a kind gift from M Rincón, Larner College of Medicine,
University of Vermont, Burlington, VT, USA), and anti-B220 (RA3-6B2). Cells were
then rocked over magnetic goat anti-rat beads (Qiagen, Germantown, MD, USA) at a
10:1 bead:cell ratio for 45 min at 4°C. Beads and bound cells were removed with a
magnet. Naïve T cells were cultured in RPMI-1640 (Corning, Manassas, VA, USA),
supplemented with 25 mM HEPES, 100 U/mL penicillin-streptomycin (ThermoFisher
Scientific, Waltham, MA, USA), 5% bovine calf serum (GE Healthcare HyClone, Logan,
UT, USA), 2.5 mg/L glucose, 2 mM glutamine, 10 μg/mL folate, 1 mM pyruvate, and 50
μM 2-mercaptoethanol (RPMI-C) and stimulated on 10 μg/mL plate-bound anti-CD3
clone 145-2C11 (Bio X Cell, West Lebanon, NH, USA) and soluble anti-CD28 ascites
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clone 37-51 (1:1000), supplemented with 50 U/mL IL-2 (Cetus, Emeryville, CA, USA) at
37°C, 5% CO2. After 2 days, activated T cells were removed from stimulation and
cultured for an additional day in RPMI-C and 50 U/mL IL-2. Cells were then washed 3
times to remove cytokines and cultured for 2-3 more days in RPMI-C supplemented with
either 50 U/mL IL-2 or 20 ng/mL IL-15 (a kind gift from Amgen, Thousand Oaks, CA,
USA). For studies of the inhibition of glycolysis, T cells were activated for 2 days in
RPMI-C medium supplemented with 50 U/mL IL-2. Cells were then washed 3 times and
cultured in RPMI-C medium with 50 U/mL IL-2 and the indicated doses of 2-deoxy-Dglucose (Sigma-Aldrich, St. Louis, MO, USA) or rapamycin (MP Biomedicals, Solon,
OH, USA) for 3 days, replacing media, cytokine, and inhibitor each day. IL-2-cultured T
cells cultured in 2-deoxy-D-glucose were centrifuged over Histopaque-1077 (SigmaAldrich) to minimize the number of dead cells in the cultures prior to use in the assays.
Alternatively, cells were washed and cultured with glucose-free RPMI-1640 (Corning)
supplemented with 100 U/mL penicillin-streptomycin, 5% bovine calf serum, 2 mM
glutamine, 10 μg/mL folate, 1 mM pyruvate, and 50 μM 2-mercaptoethanol (GF RPMIC). Cells were then cultured in GF RPMI-C supplemented with the indicated decreasing
concentrations of glucose for 3 days, replacing the media each day.
Caspase activity assay
Caspase activity was measured using the Apo-ONE Homogeneous Caspase-3/7
Assay Kit (Promega, Madison, WI, USA) according to the manufacturer’s specifications.
Samples were analyzed using a Synergy HT Plate Reader (BioTek, Winooski, VT, USA).
Cell lysis and immunoblot analysis
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Cells were lysed for 20 min on ice in Lysis Buffer A (0.5% Nonidet P-40, 150
mM NaCl, 20 mM Tris-HCl (pH 7.4), 10% glycerol, 2 mM sodium orthovanadate, and
Complete Protease Inhibitor (Roche Diagnostics, Indianapolis, IN, USA)). Protein
concentration was determined by Bradford Assay (Bio-Rad, Hercules, CA, USA).
Lysates were boiled for 5 min in Laemmli loading buffer supplemented with 2mercaptoethanol (2-ME). Proteins within the lysates were separated by SDS-PAGE on a
12% acrylamide gel and transferred to a polyvinylidene difluoride (PVDF) membrane
(Bio-Rad). Membranes were blocked in 4% milk in Tris-buffered saline with 0.1%
Tween-20 (American Bioanalytic, Natick, MA, USA) at room temperature for 1 hr. The
following antibodies were used for protein detection: anti-caspase-3, 585 rabbit
polyclonal antibody (a kind gift from Dr. Yuri Lazebnik, Cold Spring Harbor
Laboratories, Cold Spring Harbor, NY, USA), anti-caspase-8 (a kind gift from Dr.
Andreas Strasser, The Walter and Eliza Hall Institute of Medical Research, Melbourne,
Australia), anti-caspase-9, clone 5B4 (Stressgen Assay Designs, Ann Arbor, MI, USA),
anti-flotillin (BD Biosciences), GM-1 HRP (Sigma-Aldrich), anti-paxillin, clone 165 (BD
Biosciences), anti-FasL MAB5262 (R&D Systems, Minneapolis, MN, USA), anti-β-actin
(Sigma-Aldrich), anti-mouse IgG HRP, anti-rabbit IgG HRP, and anti-rat IgG HRP (all
from Jackson Laboratory). Densitometry was performed using Image Studio Lite v5 (LICOR Biotechnology, Lincoln, NE, USA).
bVAD active caspase precipitation
Cells were washed once with PBS containing 1% bovine serum albumin (PBS/1%
BSA) and once with PBS, then incubated on ice for at least 20 min with Lysis Buffer B
(0.2% Nonidet P-40,150 mM NaCl, 20 mM Tris-HCl (pH 7.4), 10% glycerol, 2 mM
80

sodium orthovanadate, and Complete Protease Inhibitor (Roche Diagnostics))
supplemented with 20 μM biotin-VAD-fmk (bVAD) (MP Biomedicals). Protein was
quantified by Bradford assay (Bio-Rad). 400–600 μg of protein in 300 μL of Lysis Buffer
B (or 250 μg of protein for lipid raft fractions with no extra buffer added) was pre-cleared
by rocking over 40 μL of Sepharose 4B beads (Sigma-Aldrich) for 2 hr at 4°C.
Supernatants were then rocked over streptavidin-Sepharose beads (ThermoFisher
Scientific) overnight at 4°C. Beads were then washed 3 times with Lysis Buffer B
without protease inhibitor and boiled for 5 min in Laemmli loading buffer supplemented
with 2-ME. For precipitations with lipid raft and non-raft fractions, an equal amount of
protein was used from each fraction for the assay.
Glutathione Immunoprecipitation
Cells were washed once with PBS/1% BSA and once with PBS, then incubated in
Lysis Buffer B supplemented with 1 mM N-ethylmaleimide (NEM) for at least 20 min on
ice. Protein was quantified by Bradford assay (Bio-Rad). 300 μg of lysate was brought to
250 μL with lysis buffer. The reduced control was incubated with 50 mM dithiothreitol
(+DTT) and rocked at 4°C for 1 hr. The reduced sample was then centrifuged through a
Micro Bio-Spin P-6 Gel Column (Bio-Rad). For the IgG control, 5 μg of mouse IgG
(Jackson Laboratory) was added to the sample. For all other samples, 2 μg of antiglutathione antibody (Virogen, Watertown, MA, USA) was added. All samples were
rocked overnight at 4°C. Samples were added to 50 μL of washed Protein G Plus Agarose
(ThermoFisher Scientific) and rocked at 4°C for 1 hr. Beads were washed and boiled in
Laemmli buffer before being loaded onto a 15% acrylamide gel. Proteins were separated
by SDS-PAGE and transferred to a PVDF membrane for immunoblot analysis.
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Metabolic analyses
Oxygen consumption rates (OCR) and extracellular acidification rates (ECAR)
were measured using the Seahorse XFe 96 Analyzer (Agilent Technologies, Santa Clara,
CA, USA) according to the manufacturer’s specifications. Analysis was performed using
the Wave Software v2.2.0 or v2.3.0.2 (Agilent Technologies).
Flow Cytometry
For surface staining, cells were washed in PBS and stained with Live/Dead
Fixable Blue Dead Cell Stain (ThermoFisher Scientific) for 25 min on ice. Cells were
washed and incubated for 25 min on ice with anti-CD25-BV421 (BioLegend, San Diego,
CA, USA), anti-CD44-PE (BioLegend), anti CD4-PE-TexasRed (ThermoFisher
Scientific), anti-CD8-PerCP-Cy5.5 (BioLegend), anti-TCRβ-PE-Cy7 (BioLegend), antiCD45RB-FITC (BioLegend). Cells were washed, fixed in 1% (v/v) methanol-free
formaldehyde, and analyzed on an LSRII (BD Biosciences).
For intracellular staining, after staining with Live/Dead Fixable Blue Dead Cell
Stain and surface antibodies as described above, cells were washed and fixed with 2%
formaldehyde (v/v) for 15 min on ice. Fixed cells were washed and permeabilized with
PBS/1% BSA supplemented with 0.03% saponin for 10 min on ice. Cells were washed
and incubated with anti-cleaved caspase-3 Alexa 647 (Cell Signaling) for 30 min on ice.
Cells were washed, fixed in 1% formaldehyde (v/v), and analyzed on an LSRII (BD
Biosciences).
All flow cytometry data was analyzed with FlowJo v10 software (FlowJo,
Ashland, OR, USA).
Cellular and mitochondrial ROS measurement
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Cellular ROS was measured using 2',7'-dichlorodihydrofluorescein
diacetate (DCFDA) (ThermoFisher Scientific). 5 x 105 cells were incubated with 1 μM
DCFDA in PBS at 37°C in the dark for 30 min. Cells were washed with cold PBS/1%
BSA and analyzed immediately by flow cytometry.
Mitochondrial ROS was quenched using MitoQ (Kelso et al., 2001). Cell cultures were
incubated with MitoQ or a DMSO control for 4 h. Cells were then stained with DCFDA,
as described above, for ROS detection.
Mitochondrial ROS was measured using the MitoB probe as previously described
(Cochemé et al., 2011). MitoB specifically targets the mitochondria and is converted to
MitoP in the presence of ROS. The ratio of MitoP/MitoB was measured using liquid
chromatography tandem mass spectrometry.
Complex I activity and mitochondrial extraction
Cells were washed with PBS/1% BSA and resuspended in STE buffer (250mM
sucrose, 5mM Tris, 1mM EGTA, pH 7.4 with HCl). Cells were homogenized and
centrifuged at 1 000 x g for 3 min at 4°C. The supernatant was then centrifuged at 10 000
x g for 10 min at 4°C. The supernatant (cytosol) was saved and the pellet (mitochondria)
was washed with STE buffer. The mitochondria were then resuspended and assayed for
Complex I activity using the Complex I Enzyme Activity Microplate Kit (MitoSciences,
Eugene, OR, USA) according to the manufacturer’s specifications. Samples were run in
parallel with mouse liver mitochondrial extracts as a positive control. Complex I rates
were calculated by dividing Complex I activity by time. Complex I rates were normalized
to mouse liver mitochondrial complex I rate.
Cell Death
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Restimulation-Induced Cell Death was induced in day 6 or 7 effector T cells by
incubation on plate-bound anti-CD3 (10 μg/mL) for 16-18 hr at 37°C. Cells were
removed and stained with Live/Dead Fixable Blue Dead Cell Stain (ThermoFisher
Scientific), fixed in 1% formaldehyde (v/v), and analyzed by flow cytometry.
As a positive control for cell death, day 6 effector T cells were incubated with 400 ng/mL
FLAG-tagged FasL (Enzo Life Sciences, Farmingdale, NY, USA) and 2 μg/mL antiFLAG antibody M-2 (Sigma-Aldrich) for 1.5 hr at 37°C. Cells were then stained with
Live/Dead Fixable Blue Dead Cell Stain (ThermoFisher Scientific) fixed in 1%
formaldehyde (v/v), and analyzed by flow cytometry.
CD4+ T cell subset differentiation
Purified CD4+ T cells were activated in complete medium on plate-bound antiCD3/soluble anti-CD28 for 2 or 3 days in the presence of differentiating cytokines (Th1:
4 ng/mL IL-12 (PeproTech, Rocky Hill, NJ, USA) plus 10 μg/mL anti-IL-4 (BioLegend);
Th2: 10 ng/mL IL-4 (PeproTech) plus 10 μg/mL anti-IFN-γ (BioLegend); Treg: 2 ng/mL
TGF-β (PeproTech) plus 100 U/mL IL-2). After differentiation, cultures were propagated
for 2 or 3 days in complete medium containing 50 U/ml IL-2 for Th1 and Th2 cells, and
100 U/mL IL-2 for Treg.
Lipid Raft Purification
Lipid rafts were separated as previously described (Misra et al., 2007). Briefly,
cells were lysed on ice for 25 min in TNE buffer (5 mM iodoacetic acid (ThermoFisher
Scientific), 150 mM NaCl, 10 mM Tris-HCl pH 7.4, 15 mM EDTA, Complete Protease
Inhibitor) supplemented with 100 mM Na2CO3 and 0.5% Triton X-100. Lysates were
sonicated and added to 60% Opti-Prep sucrose substitute (Sigma-Aldrich) to make a final
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concentration of 40% Opti-Prep. Lysates were placed in an ultracentrifuge tube and
layered over with 30% and 5% solutions of Opti-Prep diluted with TNE buffer. Samples
were centrifuged for 18 hr at 200 000 x g at 4°C. Eleven 1 mL fractions were taken
sequentially from each sample. An equal volume of each fraction was used for
immunoblot analysis.
Influenza infection of mice
Mouse-adapted influenza virus strain A/Puerto Rico/8/1934 H1N1 (PR8) virus
(Charles River Laboratories, Wilmington, MA, USA) was used to infect mice. Mice were
briefly anesthetized using 2.3% isoflurane in oxygen and infected intranasally with a
sublethal dose of PR8 (0.2 LD50) in 0.05 ml of PBS. Control mice received 0.05 ml PBS
without virus. Mice were monitored daily until harvest on day 6, at which time the
mediastinal lymph node was harvested from the influenza infected mice, and axillary,
brachial, and inguinal lymph nodes were extracted from the PBS control mice.
Lymphocytes were collected and stained for analysis by flow cytometry.
Statistical Analysis
Statistical analyses were performed using the graphing software Prism v7
(GraphPad Software, La Jolla, CA, USA). The statistical test used for each experiment is
indicated in the figure legends. The following statistical tests were used: paired and
unpaired t-test when comparing two conditions (e.g. IL-2 compared to IL-15), one-way
ANOVA with Tukey test or Dunnett test (when comparing to one control) for correction
for multiple comparisons when comparing multiple conditions for a single variable (e.g.
dose titration of 2-DG), two-way ANOVA with Sidak test or Tukey test for correction for
multiple comparisons when comparing multiple variables across multiple conditions (e.g.
85

IL-2 with and without anti-CD3 compared to IL-15 with and without anti-CD3). All data
met the assumptions of the statistical tests used and variation between the compared
groups was similar.
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2.8 Figure Legends
Figure 2.1. IL-15 drives increased oxygen consumption, complex I activity, and
mitochondrial ROS. Anti-CD3/CD28-activated T cells were cultured for 3 days in IL-2
or IL-15. (A) Oxygen consumption rate (OCR) was measured by extracellular flux
analysis. O = Oligomycin A (inhibitor of ATP synthase), F = FCCP (uncoupler of the
electron transport chain), R/A = Rotenone and Antimycin (inhibitors of complexes I and
III, respectively) (mean ± SD of 4 replicates within the one experiment shown. The graph
is representative of 2 independent experiments). (B) Complex I activity was measured in
mitochondrial (Mito) and cytosolic (Cyto) fractions of IL-2- or IL-15-cultured T cells
(the graph is representative of 2 independent experiments). (C) Complex I rates of
activity in (B) for mitochondrial fractions, normalized to the rate of activity of complex I
in mouse liver mitochondria (unpaired t-test; * indicates p<0.05; mean ± SD of data from
2 independent experiments). (D) Mitochondrial ROS were measured by the conversion of
mitoboronic acid (MitoB) to mitophenol (MitoP), and the ratio of MitoP/MitoB was
measured by liquid chromatography tandem mass spectrometry (paired t-test; * indicates
p<0.05; mean ± SEM of means from 3 independent experiments).
Figure 2.2. IL-15 induces glutathionylation of caspase-3. Anti-CD3/CD28-activated T
cells were cultured in IL-2 or IL-15 for 3 days before lysis. (A) Glutathione
immunoprecipitation (GSH IP) was performed on whole cell lysates (WCL).
Immunoprecipitations were conducted alongside a reduced control (+DTT) and an IgG
control (IgG). The WCL and GSH IP were immunoblotted for caspase-3 (the immunoblot
is representative of 3 independent experiments). (B) Densitometry of cleaved caspase-3
detected in the IL-2 and IL-15 GSH IP lanes in (A), indicative of glutathionylated
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cleaved caspase-3 (paired t-test; * indicates p<0.01; mean ± SD; n = 3 independent
experiments). (C) ROS were measured by flow cytometry using DCFDA in IL-2- or IL15-cultured T cells in the presence or absence of 200 nM mitoquinone (MitoQ) for 4 h
(two-way ANOVA with Sidak’s correction; data indicate a fold change compared to IL-2
DMSO control; NS = not significant; * indicates p<0.05; mean ± SEM; n = 3
independent experiments). (D) Caspase activity was measured by DEVD rhodamine
fluorescence in IL-2- or IL-15-cultured T cells with or without MitoQ (two-way ANOVA
with Sidak’s correction; NS = not significant; * indicates p<0.05; mean ± SD of 3
replicates within the one experiment shown. The graph is representative of 2 independent
experiments). (E) IL-2- or IL-15-cultured T cells were incubated with MitoQ (200 nM) or
DMSO for 24 h. Restimulation-induced cell death was then promoted by 16 h anti-CD3
restimulation followed by Live/Dead staining and flow cytometry (two-way ANOVA
with Tukey’s correction; NS = not significant; mean ± SD of 2 replicates).
Figure 2.3. Caspase activity parallels glycolysis and CD25 expression in T cells. (AC) T cells were activated with anti-CD3/CD28 for 2 days and cultured in IL-2 for a third
day. T cells were then washed and cultured in IL-2 or IL-15 for an additional 7 days. (A)
Baseline extracellular acidification rate (ECAR) was measured by extracellular flux
analysis at days 0, 6, and 10 (two-way ANOVA with Tukey’s correction; NS = not
significant; * indicates p<0.01; mean ± SEM of means from 3 independent experiments).
(B) CD25 expression measured daily by flow cytometry (the graph is representative of 2
independent experiments). (C) Caspase activity was measured daily by DEVD rhodamine
release (mean ± SD of 3 replicates within the one experiment shown. The graph is
representative of 2 independent experiments). (D) Anti-CD3/CD28-activated T cells were
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cultured in IL-2 or IL-15 for 3 days. For a positive control, IL-2-cultured T cells were
incubated with FasL for 1.5 h to induce caspase-3 activity and cell death. Cells were
stained for intracellular active caspase-3 and analyzed by flow cytometry (the graph is
representative of 3 independent experiments). (E, F) Purified CD4+ T cells were
differentiated into Th1, Th2, and Treg subsets by activation with anti-CD3/CD28 for 2 or
3 days along with the appropriate cytokines (see Materials and Methods). T cell subsets
were then cultured for an additional 2 or 3 days in IL-2 according to an established
protocol (Michalek et al., 2011). (E) Baseline ECAR was measured by extracellular flux
analysis (one-way ANOVA with Tukey’s correction; ** indicates p<0.0001; mean ± SD
of 5 replicates within the one experiment shown. The graph is representative of 2
independent experiments). (F) Caspase activity was measured by DEVD rhodamine
fluorescence (one-way ANOVA; ** indicates p<0.0001; mean ± SD of 3 replicates
within one experiment. The graph is representative of 2 independent experiments).
Figure 2.4. Glycolysis regulates caspase activity in effector T cells. Anti-CD3/CD28activated T cells were cultured for 3 days in IL-2 with (A) 2-deoxyglucose (2-DG, 0-5
mM). Baseline ECAR was measured (one-way ANOVA with Dunnett’s correction; **
indicates p<0.001; mean ± SEM of means from 3 independent experiments). (B, C)
Activated T cells were cultivated for 3 days in (B) IL-2 or (C) IL-15, in medium, 2deoxyglucose (2-DG, 5 mM), without glucose (No glucose), Rapamycin (300 nM), or
DMSO control. Caspase activity was measured by DEVD rhodamine fluorescence. Data
indicate a fold change compared to the control (one-way ANOVA with Dunnett’s
correction; * indicates p<0.05; ** indicates p<0.001; mean ± SD; n = 3 independent
experiments).
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Figure 2.5. Activity of caspase-3, but not caspase-8 or -9, is regulated by the
glycolytic state of effector T cells. Activated T cells were cultured for 3 days in IL-2
with or without 5 mM 2-DG. (A) Active caspases were selectively precipitated using
biotin-VAD (bVAD) and streptavidin Sepharose beads, and immunoblotted for caspases8, -9, -7, and -3 (the blot is representative of 2 independent experiments). (B)
Densitometry of active caspase-8, -9, -7, and -3 in (A) (For caspase-8, -9, and -3: twoway ANOVA with Sidak’s correction; For caspase-7: unpaired t-test; NS = not
significant; * indicates p<0.05; mean ± SD of 2 replicates). (C) Cell death was
determined by Live/Dead staining after centrifugation over Histopaque. (unpaired t-test;
mean ± SD; ** indicates p<0.01; n = 3 independent experiments). (D) Restimulationinduced cell death was promoted by 16 h anti-CD3 restimulation of IL-2-cultured T cells
cultured with or without 2-DG, and cell death determined by Live/Dead staining using
flow cytometry. Data indicate fold change compared to the unstimulated medium control
(two-way ANOVA with Sidak’s correction; NS = not significant; * indicates p<0.05;
mean ± SD of 2 replicates; n = 2 independent experiments). (E) Cell lysates of T cells
grown in the indicated conditions were immunoblotted for FasL. Controls included FasLtransfected 3T3 cells or mock-transfected 3T3 cells (the immunoblot is representative of
2 independent experiments). (F) Densitometry of FasL in (E) (one-way ANOVA; *
indicates p<0.05; ** indicates p<0.01; mean ± SD of 2 replicates).
Figure 2.6. IL-2-mediated glycolysis promotes the localization and cleavage of
caspase-3 in lipid rafts. Activated T cells were cultured for 3 days in IL-2 or IL-15. (A,
B) Cells were sonicated before fractionation in an ultracentrifuge over an Optiprep
density gradient. Fractions of 1 mL each were collected. A volume of 30 μL of each
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fraction was used to perform an immunoblot for capsase-3, GM-1 (lipid rafts), and
paxillin (non-raft) (the blot is representative of 2 independent experiments). (C)
Densitometry of the ratio of cleaved capsase-3 to pro-caspase-3 in raft and non-raft
fractions (n = 2 independent experiments). (D) bVAD precipitation of active caspases
was performed on the indicated raft and non-raft fractions and precipitates were
immunoblotted for active caspase-3 (the blot is representative of 2 independent
experiments). (E) Densitometry of active caspase-3 in raft and non-raft fractions (n = 2
independent experiments).
Figure 2.7. Caspase-3 is active in vivo in proliferating T cells after influenza
infection. Mice received influenza virus strain A/Puerto Rico/8/1934 H1N1 virus (FLU)
or PBS control intranasally and lymph nodes were extracted 6 days after infection.
Mediastinal lymph node cells (flu-infected mice) or non-mediastinal lymph node cells
(PBS control mice) were stained and analyzed by flow cytometry. (A) Representative
contour plots of live CD4+ (left) or CD8+ (right) T cells from PBS control mice (top) or
flu-infected mice (bottom) for CD44 versus active caspase-3. The two rectangular inserts
identify the CD44high (upper) and CD44low (lower) populations. All events to the right of
the vertical line are positive for active caspase-3. Numbers represent the percentage of
CD44high or CD44low gated cells that are positive for active caspase-3 (%+), and the
median fluorescent intensity of active caspase-3 (MFI). (B) Graphs of the percent
positive cells for active caspase-3 (top) and MFI (bottom) (two-way ANOVA with
Tukey’s correction; mean ± SD; * indicates p<0.001, ** indicates p<0.0001; NS = not
significant; n = 5 mice per group).
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Figure 2.1: IL-15 drives increased oxygen consumption, complex I activity, and
mitochondrial ROS
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Figure 2.2: IL-15 induces glutathionylation of caspase-3
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Figure 2.3: Caspase activity parallels glycolysis and CD25 expression in T cells
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Figure 2.4: Glycolysis regulates caspase activity in effector T cells
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Figure 2.5: Activity of caspase-3, but not caspase-8 or -9, is regulated by the
glycolytic state of effector T cells
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Figure 2.6: IL-2-mediated glycolysis promotes the localization and cleavage of
caspase-3 in lipid rafts
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Figure 2.7: Caspase-3 is active in vivo in proliferating T cells after influenza
infection
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3.1 Abstract
An effective adaptive immune response requires rapid T cell proliferation,
followed by equally robust cell death. These two processes are coordinately regulated to
allow sufficient magnitude of response followed by its rapid resolution, while also
providing the maintenance of T cell memory. Both aspects of this T cell response are
characterized by profound changes in metabolism; glycolysis drives proliferation whereas
oxidative phosphorylation supports the survival of memory T cells. While much is known
about the separate aspects of T cell expansion and contraction, considerably less is
understood regarding how these processes might be connected. We report a link between
the induction of glycolysis in CD8+ T cells and upregulation of the inhibitor of complex I
and oxidative phosphorylation, methylation-controlled J protein (MCJ). MCJ acts
synergistically with glycolysis to promote caspase-3 activity. Effector CD8+ T cells from
MCJ-deficient mice manifest reduced glycolysis and considerably less active caspase-3
compared to wild-type cells. Consistent with these observations, in non-glycolytic CD8+
T cells cultured in the presence of IL-15, MCJ expression is repressed by methylation,
which parallels their reduced active caspase-3 and increased survival compared to
glycolytic IL-2-cultured T cells. Elevated levels of MCJ are also observed in vivo in the
highly proliferative and glycolytic subset of CD4-CD8- T cells in Fas-deficient lpr mice.
This subset also manifests elevated levels of activated caspase-3 and rapid cell death.
Collectively, these data demonstrate tight linkage of glycolysis, MCJ expression, and
active caspase-3 that serves to prevent the accumulation and promote the timely death of
highly proliferative CD8+ T cells.
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3.2 Introduction
The adaptive immune response is characterized by rapid proliferation of
responding T cells followed by equally rapid cell death. These two processes need to be
tightly coordinated, lest this result in excessive expansion or loss of T cells. Whereas
much is known about the metabolic shifts leading to T cell proliferation and the death
pathways resulting in contraction, less is appreciated about the possible close linkage of
these two processes. Understanding this connection is critical to the design of T cell
immunotherapy where enormous expansion of T cells is performed ex vivo using
exogenous cytokines followed by the need for the cells to survive in vivo when infused in
patients.
T cell activation induces IL-2 and CD25 signaling, promoting IL-2-induced
glycolysis that is characterized by the activation of mTOR and the upregulation of Glut1
(Finlay et al., 2012; Ray et al., 2015). The increase in glycolysis allows cells to generate
the synthetic molecules needed for rapid proliferation and proper effector function.
Proliferative effector T cells are highly sensitive to various forms of cell death, including
Fas stimulation and cytokine withdrawal (Alderson et al., 1995; Larsen et al., 2017; Snow
et al., 2010). The cytokine IL-15 is also important in proliferation. By contrast, IL-15
reduces glycolysis and promotes oxidative phosphorylation and T cell survival to the
memory stage, although the mechanism of survival is not clear (Saligrama et al., 2014;
van der Windt et al., 2012).
In addition to the critical role of metabolism in T cell activation and proliferation,
the metabolic state of T cells may greatly influence their susceptibility to cell death.
Given that caspases are frequently the mediators of cell death, we considered that
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metabolism might regulate the activity of certain caspases, and as such, set a level of
susceptibility to cell death. We have previously observed that IL-2 selectively promotes
caspase-3 activity whereas IL-15 inhibits its activation. Knowing that IL-15 promotes
activity of complex I of the electron transport chain and oxidative phosphorylation
(Secinaro et al., 2018; van der Windt et al., 2012), we considered that other mechanisms
of reducing glycolysis and enhancing complex I activity might also reduce caspase-3
activity.
Methylation-controlled J protein (MCJ) was recently identified as a negative
regulator of complex I (Hatle et al., 2013). MCJ is a member of the DNAJ family of
proteins, encoded by the gene dnajc15 (Hatle et al., 2013; Hatle et al., 2007; Shridhar et
al., 2001). MCJ is located at the inner mitochondrial membrane and interacts with
complex I of the electron transport chain (Hatle et al., 2013). This interaction decreases
complex I activity and reduces supercomplex formation of members of the electron
transport chain, which results in a decrease in mitochondrial respiration (Champagne et
al., 2016). MCJ-deficient T cells thus manifest increased complex I activity,
mitochondrial respiration, and provide more effective memory than wild-type T cells
(Champagne et al., 2016). We therefore considered that regulation of MCJ expression
may be a component of the linkage between metabolism and cell death.
Here, we observe that as T cells enter glycolysis via IL-2 in vitro to become
effector T cells they strongly upregulate MCJ. Paralleling this was an increase of caspase3 activity. Similar findings were observed in vivo with rapidly proliferating glycolytic
CD4-CD8- T cells from Fas-deficient lpr mice. By contrast, in MCJ-deficient IL-2
effector T cells caspase-3 activity was decreased. IL-15-culutured T cells downregulated
107

MCJ expression through its gene methylation, which also paralleled reduced caspase-3
activity. These findings establish a close relationship between glycolysis, MCJ, and
mitochondrial respiration, with a level of caspase-3 activity that is independent of Fas
engagement.

3.3 Results
3.3.1 Induction of glycolysis by IL-2 increases expression of MCJ and reduced
complex I activity which is reversed by IL-15
We modeled in vitro the metabolic switch that occurs in CD8+ T cells during the
transition from naïve to effector and then to memory T cells by analyzing freshly purified
CD8+ T cells before, and at various times after, activation with anti-CD3/CD28. After
two days, cells were removed from the activation stimuli and cultured for an additional
day in IL-2, then washed and recultured for an additional three days in cytokines known
to induce differing metabolic states; IL-2 to induce glycolysis and effector T cells versus
IL-15 to induce oxidative phosphorylation and memory T cells (van der Windt et al.,
2012). IL-2-cultured activated CD8+ T cells manifested a rapid increase in glycolysis, as
measured by extracellular acidification rate (ECAR) and a low oxygen consumption rate
(OCR) on day 6, whereas IL-15-cultured CD8+ T cells had the opposite metabolic profile,
consistent with oxidative phosphorylation, in agreement with previous reports (van der
Windt et al., 2012) (Fig. 3.1A).
As oxygen consumption is primarily due to mitochondrial activity of the electron
transport chain, we examined complex I activity in naïve versus IL-2-cultured CD8+ T
cells. Corresponding to the decrease in OCR as naïve T cells became glycolytic effector
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T cells with IL-2 stimulation, we observed a decrease in complex I activity in IL-2 CD8+
T cells (Fig. 3.1B). We further investigated the possibility that the metabolic switch
between oxidative phosphorylation and glycolysis reflected changes in methylationcontrolled J protein (MCJ), which physically associates with complex I and inhibits its
activity (Hatle et al., 2013). MCJ expression in naïve CD8+T cells increased following
activation with IL-2, peaking at days 3-5. In contrast, MCJ expression decreased rapidly
in IL-15-cultured CD8+ T cells compared to IL-2, resembling resting naïve CD8+T cells
(Fig. 3.1C). Of further interest was that paralleling the increase in MCJ expression with
IL-2, CoxIV (a subunit of complex IV) decreased, reaching low expression levels at days
3-4, and then increasing toward initial levels. This shows that the increase in MCJ was
not the result of a global increase in mitochondrial mass, as reflected in the MCJ:CoxIV
ratio (Fig. 3.1C). IL-15-cultured-CD8+ T cells manifested the opposite profile with
persistently high CoxIV, compared to their low levels of MCJ (Fig. 3.1C).
3.3.2 Inhibition of DNA methyltransferases results in the expression of MCJ in IL15-cultured CD8+ T cells
Given the differences in MCJ expression between glycolytic IL-2-cultured cells
and non-glycolytic IL-15-cultured cells, we investigated the possibilities that IL-15
reduces MCJ expression or glycolysis drives MCJ expression. The gene encoding MCJ,
dnajc15, is known to be regulated by methylation-induced suppression (Shridhar et al.,
2001; Strathdee et al., 2004). To investigate whether the reduction in MCJ by IL-15 was
related to gene methylation we cultured activated CD8+ T cells in IL-15 with 1 μM 5azacytidine (5azaC), a DNA methyltransferase inhibitor, or with an equivalent
concentration of DMSO as a vehicle control for 2 days starting at day 3. We observed
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that 5azaC treatment resulted in a substantially increased expression of MCJ protein, and
this was to a much greater extent than for complex I component NDUFA9, or complex
IV component CoxIV (Fig. 3.2). This was reflected in the MCJ:NDUFA9 ratio,
indicating 5azaC treatment did not globally increase mitochondrial proteins (Fig. 3.2).
3.3.3 Glucose utilization increases MCJ protein expression
We directly examined the influence of glycolysis on MCJ expression using 2deoxy-D-glucose (2-DG), which inhibits glycolysis after its phosphorylation by
hexokinase (Wick et al., 1957). We cultured activated CD8+ T cells in IL-2 for 3 days in
the absence or presence of 5 mM 2-DG, starting at day 3. Cells cultured with IL-2 plus 2DG expressed dramatically less MCJ compared to IL-2 alone (Fig. 3.3). Such decreases
were not observed for NDUFA9 or CoxIV, as reflected in the MCJ:NDUFA9 ratio (Fig.
3.3). These data demonstrate a link between MCJ expression and glucose utilization in
CD8+ T cells.
3.3.4 Reduced glycolysis and caspase-3 activity of T cells from MCJ-deficient mice.
Given the link between glucose utilization and MCJ expression, we measured
glycolysis in IL-2-cultured effector CD8+ T cells derived from either MCJ-deficient
(MCJ-/-) mice or wild-type (WT) control mice by extracellular flux analysis at day 4. The
MCJ-/- T cells were less glycolytic than the WT T cells (Fig. 3.4A). We have previously
reported that glycolysis drives caspase-3 activity (Secinaro et al., 2018). Since MCJ-/- T
cells were less glycolytic than WT T cells, we hypothesized the MCJ-/- T cells would
have reduced caspase-3 activity. Cell lysates were prepared in the presence of biotinVAD (bVAD), which labels active caspases, on day 6 (Zhou et al., 2006). Active
caspases were then precipitated from lysates with avidin-sepharose, and precipitates
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immunoblotted for caspase-3 and caspase-8. We observed that MCJ-/- CD8+ T cells
manifested a pronounced decrease in active caspase-3 and a modest increase in active
caspase-8 (Fig. 3.4B). CD8+ T cells deficient in MCJ have been shown previously to be
resistant to cell death during a simulated immune contraction phase using cytokine
withdrawal (Champagne et al., 2016). However, the mechanism for this increased
survival is not known. Since cell death by either cytokine withdrawal or T cell receptor
restimulation is mediated by caspases (Snow et al., 2010), we examined whether this
resistance to cell death extended also to restimulation-induced cell death (RICD). We
restimulated day 6 effector WT or MCJ-/- T cells with anti-CD3 overnight, and measured
cell death by LiveDead stain and flow cytometry. This revealed a trend toward a decrease
in cell death and caspase activity after restimulation in the MCJ-/- T cells compared to
WT, though the difference did not reach statistical significance (Fig. 3.4C and D).
3.3.5 Highly proliferative and glycolytic T cells in vivo manifest high levels of MCJ
and increased active caspase-3
To examine whether these observations in vitro extend to proliferative glycolytic
T cells in vivo, we examined a highly proliferative T cell subset that exists in Fasdeficient lpr mice. CD4-CD8- (double negative, DN) T cells accumulate in lpr mice with
age and our previous studies have shown that by in vivo BrdU labeling a remarkable 18%
of this subset undergoes cell cycling in a 24 h period compared with only about 5-6% of
the CD4+ and CD8+ (B220-) T cells from the same mice (Fortner et al., 2017). Consistent
with this, we observed that freshly isolated lpr DN T cells were highly glycolytic, as
revealed by ECAR, compared to the B220- T cells (Fig. 3.5A). In parallel with their high
glycolytic state, the DN T cells also expressed high levels of MCJ compared to the B220111

T cell subset (Fig. 3.5B). Similar increases in NDUFA9 or CoxIV were not observed in
the DN population, as reflected in the MCJ:NDUFA9 ratio (Fig. 3.5B).
Given the increased glycolysis and MCJ expression in the DN T cells, we
examined whether there was also an increase in caspase-3 activity. We first measured
caspase-3 activity by flow cytometry and found a five-fold increase in cells positive for
active caspase-3 in the DN T cells compared to the B220- T cells (Fig. 3.6A). This was
confirmed by bVAD precipitation (Fig. 3.6B). This paralleled an almost two-fold
increase in spontaneous cell death in the DN T cells compared to B220- T cells (Fig.
3.6C).
3.4 Discussion
The current findings highlight the coordinated regulation between induction of
glycolysis and the negative regulation of mitochondrial respiration and oxygen
consumption in the electron transport chain (ETC) in T cells. We show as resting naïve
CD8+ T cells are activated and increase glycolysis in the presence of IL-2, they decrease
electron transport and oxygen consumption by reducing expression of the ETC
complexes. Congruently, expression of the complex I negative regulator methylationcontrolled J protein (MCJ) is increased, further reducing electron transport and oxidative
phosphorylation (OXPHOS). The presence of MCJ also acts synergistically with
glycolysis to promote caspase-3 activation. This likely acts as a safeguard to prevent the
accumulation of highly proliferative CD8+ T cells that might cause damage to selftissues.
The metabolic switch from OXPHOS in naïve and memory T cells to glycolysis
in effector T cells is crucial for supporting their rapid proliferation and synthetic capacity.
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Under such proliferative conditions, it is important to shunt glucose metabolites into
synthetic pathways, such as the pentose phosphate pathway, rather than the Krebs cycle
and ATP production by the ETC. It may thus be beneficial in certain instances for
glycolytic T cells to actively suppress the ETC by reducing expression of its components
as well as upregulating an inhibitor, MCJ. This notion is consistent with the observation
that inhibition of glycolysis with 2-DG decreased the MCJ:NDUFA9 ratio.
The expansion of proliferative effector T cells is paralleled by an increase in
caspase-3 activity, which sensitizes them to restimulation-induced cell death. We have
previously shown that caspase-3 activity is regulated in part by the glycolytic state of the
cell, and caspase-3 activity is also reduced in the presence of 2-DG (Secinaro et al.,
2018). Activated CD8+ T cells deficient in MCJ manifest increased oxygen consumption
compared to wild-type cells, and an increased memory response to influenza (Champagne
et al., 2016). This resembles IL-15-cultured T cells, which also have increased oxygen
consumption and reduced active caspase-3 compared to IL-2-cultured T cells (Saligrama
et al., 2014; Secinaro et al., 2018; van der Windt et al., 2012). As both IL-15 and MCJ
deficiency contribute to increased T cell memory, their common reduction in active
caspase-3 is likely a significant contributing factor in enhancing their survival.
How IL-15 and MCJ-deficiency might inhibit caspase-3 activity is uncertain at
present, but two possible mechanisms are conceivable. One is that the increased oxygen
consumption might result in increased reactive oxygen species that could inactivate
caspase-3 by glutathionylation or nitrosylation of caspase-3 at the critical cysteine in the
enzymatic pocket (Huang et al., 2008b; Mitchell and Marletta, 2005b). We have observed
this for IL-15-cultured T cells compared to IL-2-cultured T cells (Saligrama et al., 2014;
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Secinaro et al., 2018). A second process would be preventing caspase-3 acylation and
hence migration to lipid rafts and its self-activation. In preliminary studies we have
observed that IL-2 promotes acylation of caspase-3.
The lpr CD4-CD8- (DN) T cells provided a useful in vivo source of rapidly
proliferating T cells in which to test our in vitro observations. We have previously shown
using in vivo BrdU labeling of proliferating cells that a remarkable 18% of the DN T cells
in lpr mice divide within a given 24 h period (Fortner et al., 2017). This extraordinary
rate of proliferation was paralleled by a high rate of glycolysis as well as elevated levels
of MCJ. The high levels of caspase-3 activity in lpr DN T cells paralleled their rapid cell
death ex vivo, which was obviously independent of Fas expression since Fas is absent on
lpr T cells. This serves to underscore that caspase-3 activity in highly proliferative T cells
is likely independent of death receptor ligation. This is also consistent with our previous
observations that whereas caspase-3 activity is higher in IL-2-cultured T cells than IL-15cultured T cells, caspase-8 activity is quite similar, or even slightly higher, in IL-15cultured T cells (Saligrama et al., 2014). Similarly, in the current studies MCJ-deficient
IL-2-cultured T cells manifested as much or more active caspase-8 than wild-type IL-2cultured T cells, despite MCJ-deficient T cells having greatly reduced active caspase-3.
Thus, caspase-3 activity in proliferating T cells is independent of active upstream
caspase-8.
The elevated expression of MCJ in glycolytic T cells may serve a variety of
critical functions. By inhibiting complex I and electron transport, it may reduce ROS
generation, which could reduce ROS-mediated inactivation of caspase-3 (Saligrama et
al., 2014; Secinaro et al., 2018) and promote susceptibility to cell death of rapidly
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proliferating T cells. Increased MCJ could thus help divert carbon fuel sources away from
mitochondrial respiration and toward anabolic pathways, as is seen in actively
proliferating IL-2-cultured T cells.
The current findings establish a close linkage between active T cell proliferation,
glucose utilization, and activation of caspase-3. That glycolysis promotes activation of
selectively caspase-3, whereas oxidative phosphorylation actively inhibits caspase-3
activity through glutathionylation and S-nitrosylation, underscores the tight regulation of
caspase-3 activity by the metabolic state of T cells. Such a linkage may represent an
adaptation to ensure that proliferating glycolytic T cells do not escape regulation that
might promote tumor progression or an autoimmune diathesis. These observations may
also be highly relevant to providing optimal numbers of T cells for immunotherapy, such
as with chimeric antigen receptor (CAR)-T cells. This requires the ex vivo expansion of
very large numbers of T cells often with IL-2, followed by infusion into patients, where
there may be negligible amounts of IL-2, which could result in considerable rapid loss of
T cells (Geyer et al., 2018; Hollyman et al., 2009; Tumaini et al., 2013). However,
reducing caspase-3 activity through the inhibition of MCJ in the infused T cells might
considerably augment their survival.
3.5 Materials and methods
Mice
C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME, USA), MRL/MpJFaslpr/J mice (Jackson Laboratory), MCJ-/- mice (Hatle et al., 2013), were housed in an
American Association for Accreditation of Laboratory Animal Care (AAALAC)approved animal facility at the University of Vermont Larner College of Medicine.
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Tissues from MCJ-/- and C57BL/6J mice were harvested at 2-6 months of age and tissues
from MRL/MpJ-Faslpr/J mice were harvested at 4 months of age. Protocols were
approved by the Institutional Animal Care and Use Committee.
Cell purification
CD8+ T cells were purified by negative selection from mouse lymph nodes
(axillary, inguinal, brachial, cervical) and spleens as described previously (Saligrama et
al., 2014). In brief, tissues were homogenized through nylon mesh and Gey’s solution
was used to lyse red blood cells. Combined splenocytes and lymph node cells were
incubated for 30 min on ice with the following antibodies: anti-MHC class II
(M5/114/15/2), anti-B220 (RA3-6B2), anti-CD11b (M1/70), and anti-CD4 (GK1.5).
Cells were then rocked with goat anti-rat coated magnetic beads (Qiagen, Germantown,
MD, USA) at a 10:1 bead:cell ratio for 45 min at 4°C. Beads and bound cells were
removed with a magnet.
CD4-CD8- B220+ double negative (DN) and B220- (CD4+ + CD8+) T cells were
purified from the lymph nodes of MRL/MpJ-Faslpr/J in the same manner with the
following antibodies: DN T cells; anti-MHC class II (M5/114/15/2), anti-CD11b
(M1/70), anti-CD4 (GK1.5), anti-CD8 (Tib105), and anti-kappa (187.1). B220- T cells;
anti-MHC class II (M5/114/15/2), anti-CD11b (M1/70), and anti-B220 (RA3-6B2). Wildtype lymphocytes were obtained from C57BL/6J mouse lymph nodes.
Cell culture
Naïve CD8+ T cells were cultured in RPMI-1640 (Corning, Manassas, VA, USA),
supplemented with 25 mM HEPES, 100 U/mL penicillin-streptomycin (ThermoFisher
Scientific, Waltham, MA, USA), 50 μM 2-mercaptoethanol, 5% bovine calf serum (GE
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Healthcare HyClone, Logan, UT, USA), 2.5 mg/L glucose, 1 mM pyruvate, 2 mM
glutamine, and 10 μg/mL folate (RPMI-C), and stimulated on 10 μg/mL plate-bound antiCD3 clone 145-2C11 (Bio X Cell, West Lebanon, NH, USA) and soluble anti-CD28
ascites clone 37-51 (1:1000), supplemented with 50 U/mL IL-2 (Cetus, Emeryville, CA,
USA) at 37°C and 5% CO2 for 2 days. The activated CD8+ T cells were then removed
from stimulation and cultured in RPMI-C and 50 U/mL IL-2 for an additional day. For
studies comparing IL-2- to IL-15-cultured CD8+ T cells, the cells were then washed 3
times to remove cytokines and cultured in RPMI-C supplemented with either 50 U/mL
IL-2 or 20 ng/mL IL-15 (a kind gift from Amgen, Thousand Oaks, CA, USA) for 3 days
or the number of days indicated. For studies of the inhibition of glycolysis, cells were
cultured in RPMI-C medium with 50 U/mL IL-2 with or without 5 mM 2-deoxy-Dglucose (Sigma-Aldrich, St. Louis, MO, USA) for 3 days. For studies inhibiting DNA
methylation, cells were washed 3 times to remove cytokines and cultured in RPMI-C
supplemented with 20 ng/mL IL-15 and 1 μM 5-azacytidine (Sigma-Aldrich) or an equal
concentration of DMSO for 2 days.
Biotin-VAD precipitation of active caspases
Cells were washed once with PBS/1% BSA, washed again with PBS, then lysed
for 30 min on ice in Lysis Buffer supplemented with 20 μM biotin-VAD-fmk (bVAD)
(MP Biomedicals, Solon, OH, USA). Protein was quantified by Bradford assay. 400-600
μg of protein in 300 μL of Lysis Buffer was rocked with 40 μL of Sepharose 4B beads
(Sigma-Aldrich) at 4°C for 2 hr. The beads were removed and the supernatants were
rocked with 60 μL streptavidin-Sepharose beads (ThermoFisher Scientific) at 4°C
overnight. The beads bound with active caspases were washed 3 times with Lysis Buffer
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without protease inhibitor, then boiled for 5 min in Laemmli loading buffer supplemented
with 2-ME and analyzed by immunoblot for active caspases as described below.
Immunoblot assays
Cells were washed in PBS containing 1% bovine serum albumin (PBS/1% BSA),
washed again with PBS, then lysed for 30 min on ice in Lysis Buffer (0.5% Nonidet P40, 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 2 mM sodium orthovanadate, 10%
glycerol, and Complete Protease Inhibitor (Roche Diagnostics, Indianapolis, IN, USA)).
Protein concentration of each lysate was determined by Bradford Assay (Bio-Rad,
Hercules, CA, USA). Lysates were boiled in Laemmli loading buffer supplemented with
2-mercaptoethanol (2-ME) for 5 min. Proteins were separated by SDS-PAGE on a 15%
acrylamide gel and transferred to a polyvinylidene difluoride (PVDF) membrane (BioRad). Membranes were blocked in 4% milk in Tris-buffered saline with 0.1% Tween-20
(American Bioanalytic, Natick, MA, USA) at room temperature for 1 hr. The following
antibodies were used for protein detection: anti-caspase-3, 585 rabbit polyclonal antibody
(a kind gift from Dr. Yuri Lazebnik, Cold Spring Harbor Laboratories, Cold Spring
Harbor, NY, USA), anti-caspase-8 (a kind gift from Dr. Andreas Strasser, The Walter and
Eliza Hall Institute of Medical Research, Melbourne, Australia), anti-MCJ (Hatle et al.,
2007), anti-CoxIV (Cell Signaling, Danvers, MA, USA), anti-NDUFA9 (Abcam,
Cambridge, UK), anti-β-actin (Sigma-Aldrich), anti-mouse IgG HRP, anti-rabbit IgG
HRP, and anti-rat IgG HRP (all from Jackson Laboratory). Densitometry was performed
using ImageQuant v8.1 software (GE Healthcare, Chicago, IL, USA).
Metabolic analysis
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Extracellular acidification rates (ECAR) and oxygen consumption rates (OCR)
were measured with the Seahorse XFe 96 Analyzer (Agilent Technologies, Santa Clara,
CA, USA) according to the manufacturer’s specifications. Analysis was performed with
the Wave Software v2.4 or v2.6 (Agilent Technologies).
Flow cytometry of active caspase-3
Cells were washed in PBS and stained in PBS with Live/Dead Fixable Blue Dead
Cell Stain (ThermoFisher Scientific) on ice for 25 min. Cells were washed with PBS/1%
BSA and fixed with 2% formaldehyde (v/v) on ice for 15 min. The fixed cells were then
washed with PBS/1% BSA and permeabilized with PBS/1% BSA supplemented with
0.03% saponin (PBS/1% BSA/0.03% saponin) on ice for 10 min. Fixed and
permeabilized cells were then washed and incubated with anti-cleaved caspase-3 Alexa
647 (Cell Signaling) in PBS/1% BSA/0.03% saponin on ice for 30 min. Cells were
washed, fixed in 1% formaldehyde (v/v), and analyzed on an LSRII (BD Biosciences).
Cell death
Restimulation-induced cell death was induced in day 6 wild type (WT) or MCJ-/CD8+ T cells by incubation on plate-bound anti-CD3 (10 μg/mL) for 16-18 hr at 37°C.
Cells were removed from the plate and stained with Live/Dead Fixable Blue Dead Cell
Stain (ThermoFisher Scientific), fixed in 1% formaldehyde (v/v), and analyzed by flow
cytometry.
Complex I activity measurement
Cells were washed twice with PBS then resuspended in PBS and assayed for
complex I activity using the Complex I Enzyme Activity Microplate Kit (MitoSciences,
Eugene, OR, USA) according to the manufacturer’s specifications. 40 – 100 μg of protein
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was used for each sample. Complex I rates were calculated per microgram of protein
used in the assay.
Statistical analysis
Statistical analyses were performed using the graphing software Prism v7
(GraphPad Software, La Jolla, CA, USA). The following statistical tests were used:
paired and unpaired t-test when comparing two conditions (e.g. DMSO compared to
treatment), one-way ANOVA with Tukey’s test for correction for multiple comparisons
when comparing multiple conditions (e.g. naïve compared to Day 2 compared to Day 6)
and two-way ANOVA with Sidak test for correction for multiple comparisons when
comparing multiple variables across multiple conditions (e.g. wild-type versus MCJ-/with and without anti-CD3 restimulation). All data met the assumptions of the statistical
tests used and variation among the compared groups was similar.
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3.9 Figure Legends
Figure 3.1. MCJ expression is upregulated with the induction of glucose utilization
in CD8+ T cells. (A-C) CD8+ T cells were activated for 2 days with adherent antiCD3/CD28, removed and cultured for a third day in IL-2, then washed and cultured for 3
additional days in either IL-2 or IL-15. (A) Relative baseline extracellular acidification
rate (ECAR) and oxygen consumption rate (OCR) of CD8+ T cells, measured by
extracellular flux analysis at days 0, 2, and 6 (one-way ANOVA with Tukey’s correction;
mean ± SD; * indicates p<0.05; ** indicates p<0.01; *** indicates p<0.0001; n = 3
independent experiments). (B) Complex I activity in naïve or day 6 IL-2-cultured CD8+ T
cells (t-test; mean ± SD; *** indicates p<0.0001; n = 3 independent experiments). (C)
Immunoblot and densitometry (normalized to actin) for methylation-controlled J (MCJ)
protein, cytochrome c oxidase subunit IV (CoxIV), and actin in whole cell lysates of IL2- or IL-15-cultured CD8+ T cells, day 0 through day 6 (blot and graphs are
representative of 2 independent experiments). Graph of the MCJ:CoxIV ratio
(representative of 2 independent experiments).
Figure 3.2. Inhibition of DNA methylation increases MCJ expression in IL-15cultured CD8+ T cells. Anti-CD3/CD28-activated CD8+ T cells were cultured in IL-15
supplemented with 1 μM 5-azacytidine (5azaC) or an equivalent volume of DMSO for 48
hours. Whole cell lysates were immunoblotted for MCJ, NDUFA9, CoxIV, and actin. Bar
graph represents densitometry quantification of MCJ normalized to actin and the
MCJ:NDUFA9 ratio (t-test; mean ± SD; * indicates p<0.05; MCJ:NDUFA9 ratio p =
0.1707; n = 3 independent experiments; blot is representative of 3 independent
experiments).
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Figure 3.3. Inhibition of glycolysis decreases MCJ expression. Anti-CD3/CD28
activated CD8+ T cells were cultured in IL-2 ± 5 mM 2-deoxyglucose for 3 days. Whole
cell lysates were immunoblotted for MCJ, NDUFA9, CoxIV, and actin. Bar graphs
represent the densitometry quantification of MCJ normalized to actin, and the
MCJ:NDUFA9 ratio (t-test; mean ± SD; * indicates p<0.05; ** indicates p<0.01; n = 3
independent experiments; blot is representative of 3 independent experiments).
Figure 3.4. MCJ deficiency reduces glycolysis and caspase-3 activity CD8+ T cells.
Day 2 anti-CD3/CD28-activated wild-type (WT) or MCJ-deficient (MCJ-/-) CD8+ T cells
were cultured in IL-2 for an additional (A) 2 or (B-D) 4 days. (A) ECAR was measured
by extracellular flux analysis. Bar graph is a summary of 5 samples in one experiment (ttest; mean ± SD; *** indicates p<0.0001; representative of 2 independent experiments).
(B) Active caspases were precipitated from WT or MCJ-/- whole cell lysates using biotinVAD (bVAD). Whole cell lysates and bVAD precipitates were immunoblotted for
caspase-8 and caspase-3. Bar graph indicates fold change in active caspase-3 compared to
WT (t-test; mean ± SD; *** indicates p<0.0001; n = 3 independent experiments). (C-D)
On day 6 WT or MCJ-/- cells were restimulated overnight ± 10 μg/mL anti-CD3. (C) Cell
death was measured by Live/Dead staining and flow cytometry (Two-way ANOVA; p =
0.1263; n = 3 independent experiments). (D) Caspase activity was measured by DEVDrhodamine fluorescence (Two-way ANOVA; p = 0.0912; n = 3 independent
experiments).
Figure 3.5. MCJ expression is increased in vivo in highly glycolytic CD4-CD8- T cells
from lpr mice. Freshly isolated CD4-CD8- double negative (DN) T cells or CD4+ + CD8+
(B220-) T cells from the same lpr mice were purified from lymph nodes by negative
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selection. (A) ECAR was measured by extracellular flux analysis. Bar graph is a
summary of 5 samples in one experiment (t-test; mean ± SD; *** indicates p<0.0001;
representative of 2 independent experiments). (B) Whole cell lysates were
immunoblotted for MCJ, NDUFA9, CoxIV, and actin. Bar graphs represent the
densitometry quantification of MCJ normalized to actin, and the MCJ:NDUFA9 ratio
(mean ± SD; n = 2 independent experiments).
Figure 3.6. Cell death and active caspase-3 are increased in CD4-CD8- T cells from
lpr mice. Freshly isolated CD4-CD8- double negative (DN) T cells or CD4+ + CD8+
(B220-) T cells from the same lpr mice were purified from lymph nodes by negative
selection. (A) Representative contour plot of flow cytogram for active caspase-3. The box
indicates the gate for active caspase-3 based on isotype control staining. Number inserts
indicate the percent active caspase-3-positive cells. Bar graph is a summary of
quantification of percent active caspase-3-positive cells from 3 samples in one
experiment (t-test; mean ± SD; *** indicates p<0.0001; plots and bar graph are
representative of 2 independent experiments). (B) bVAD precipitation of active caspases
from DN T cells, B220- T cells, and wild-type lymphocytes (WT), immunoblotted for
caspase-3. Graph is of the relative densitometry of active caspase-3. (C) Cell death was
measured by Live/Dead staining and flow cytometry in DN or B220- T cells after
overnight incubation at 37°C (t-test; mean ± SD; *** indicates p<0.0001; bar graph
depicts 3 samples from one experiment and is representative of 2 independent
experiments).
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Figure 3.1: MCJ expression is upregulated with the induction of glucose utilization
in CD8+ T cells.
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Figure 3.2: Inhibition of DNA methylation increases MCJ expression in IL-15cultured CD8+ T cells
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Figure 3.3: Inhibition of glycolysis decreases MCJ expression
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Figure 3.4: MCJ deficiency reduces glycolysis and caspase-3 activity CD8+ T cells
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Figure 3.5: MCJ expression is increased in vivo in highly glycolytic CD4-CD8- T cells
from lpr mice
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Figure 3.6: Cell death and active caspase-3 are increased in CD4-CD8- T cells from
lpr mice
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CHAPTER 4: DISCUSSION
The work presented in this dissertation aimed to answer two questions related to
the links among T cell metabolism, proliferation, and death:
1. Does metabolism regulate caspase activity in effector T cells?
2. Are T cell proliferation and contraction linked?
The results are summarized in the following section, and the implications of those results
are discussed in the context of what is currently known. Lastly, some potential future
studies are presented as the future directions of this dissertation.
4.1 Summary of Results
The work of this dissertation is presented in full in Chapter 2 and Chapter 3. The
findings describe a novel metabolic regulation of caspase-3 activity by glycolysis in
proliferating T cells, and thus a metabolic link between T cell proliferation and
contraction.
4.1.1 Metabolism regulates caspase activity in effector T cells
The findings presented in Chapter 2 describe the metabolic regulation of caspase3 activity in proliferating T cells. Glycolysis, which is promoted in proliferating T cells
cultured in IL-2, drives caspase-3 activity, and inhibition of glycolysis reduces caspase-3
activity. Caspase-3 clusters in lipid rafts in glycolytic T cells, but not non-glycolytic cells,
indicating a potential mechanism through which glycolysis drives caspase-3 activity.
Non-glycolytic T cells cultured in IL-15, which favors oxidative phosphorylation,
produce mitochondrial ROS that is responsible for decreasing caspase-3 activity through
glutathionylation of a critical cysteine in the enzymatic pocket. Finally, T cells that
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proliferate in vivo in response to a flu infection also have increased caspase-3 activity
compared to non-proliferating T cells.
4.1.2 T cell proliferation and contraction are linked by metabolism
The findings in Chapter 3 describe a connection between proliferation and
contraction in T cells. T cell contraction is marked by cell death and a transition from
glycolysis to oxidative phosphorylation in the surviving cells. The results show that as
glycolysis increases in proliferating T cells, the expression of certain electron transport
chain (ETC) proteins decreases whereas the expression of the complex I negative
regulator, methylation-controlled J protein (MCJ), increases. As T cells become memorylike, through culture in IL-15, glycolysis and MCJ expression decrease, while the ETC
proteins increase in expression. Inhibition of glucose utilization reduces MCJ expression,
indicating expression is driven by glucose utilization. T cells deficient in MCJ were
found to have a decrease in caspase-3 activity as well as a decreased sensitivity to cell
death. Finally, CD4-CD8- T cells, which are highly proliferative, display elevated levels
of glycolysis and MCJ expression.
4.2 Synthesis of Findings and Implications
The findings presented in this dissertation help to fill gaps in the overall
understanding of how T cells integrate signals from the tissue environment, such as the
cytokine milieu, into changes in metabolism, and how those changes in metabolism
contribute to the survival or death of the cell. This work has implications not only in
autoimmune disease, but also in the immune response to cancer or an infection. In
particular, these findings help explain why stronger T cell activation, such as that
provided by superantigens like staphylococcal enterotoxin B (SEB), is correlated with
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faster proliferation and faster contraction (Weber et al., 2000). Faster proliferation would
need a greater induction of glycolysis and, consequently, result in greater caspase-3
activation. The way in which T cells integrate an external signal into a change in
metabolism and how metabolism influences cell fate may be more broadly applicable to
other cells in the immune system, and even non-immune cells.
4.2.1 Influence of the tissue cytokine environment on T cell metabolism
The cytokine environment is a critical regulator of T cell function. During
activation and the effector response, IL-2 supports T cell growth and proliferation. This
support is mediated by the induction of glycolysis, which allows for carbons coming from
glucose to be used to generate amino acids, nucleotides, energy intermediates such as
NADPH, and lipids, all of which are needed as the cell grows and produces effector
molecules. IL-15 plays a role in the maintenance of T cells through homeostatic
proliferation (Alves et al., 2003). Dysregulation of IL-15 expression can cause
autoimmune disease, such as rheumatoid arthritis, in which the synovial fluid is rich in
IL-15 and low in IL-2 (McInnes and Liew, 1998a; Waldmann, 2013). Elevated
expression of IL-15 could promote excessive homeostatic proliferation and the generation
of cytotoxic CD8+ T cells that have the potential to induce autoimmune disease (Alves et
al., 2003; King et al., 2004). Targeting the cytokine environment is one potential method
to reduce autoimmune disease. For example, anti-IL-15 therapy has been used to treat
both rheumatoid arthritis and celiac disease (Baslund et al., 2005; Richmond et al., 2018;
Waldmann, 2013).
It is possible that targeting metabolism could be a useful stand-alone treatment or
combination therapy for autoimmune diseases. IL-15 induces mitochondrial metabolism
136

and oxidative phosphorylation, so reducing those metabolic pathways could reverse the
survival effect that IL-15 has on T cells. Mitochondrial ROS generation could be targeted
with antioxidants such as mitoQ, which could increase caspase activity enough to induce
death in the autoreactive cells.
Understanding the relationship between the cytokine environment and T cell
metabolism can also assist in finding novel ways to activate Tregs. Whereas IL-15
induces cytotoxic T cell proliferation and survival, Tregs are often inactive or decreased
in a number in autoimmune diseases, and promoting Treg function in affected tissues is a
potential treatment (Bluestone et al., 2015; Grant et al., 2015). A recent study identified
TGF-β as a cytokine that can induce different metabolic states in two Treg subsets;
inducible Tregs (iTregs, generated in vitro and similar to peripheral Tregs generated from
naïve CD4+ T cells in vivo) and thymic Tregs (tTregs, generated in the thymus during T
cell development) (Priyadharshini et al., 2018). Currently, it is thought that tTregs
recognize self-peptide:MHC complexes and are important for restraining immune cell
migration to within the lymphatic system. iTregs are thought to promote immune
suppression during inflammation (Shevach and Thornton, 2014). The study found that
tTregs undergo mTOR-dependent glycolysis, which is reduced in the presence of TGFβ.
Conversely, iTregs undergo oxidative phosphorylation due to the presence of TGFβ.
These data suggest that manipulation of the cytokine environment with TGFβ could
induce a metabolic switch and promote tolerance-inducing iTregs.
4.2.2 Mechanisms of metabolic switching
Proliferating T cells are known to induce glycolysis through IL-2 signaling while
naïve and memory T cells induce oxidative phosphorylation, which has been linked to IL137

15 signaling (van der Windt et al., 2012). Less is known about the mechanism through
which these cytokines induce the corresponding metabolic state, and how T cells can
switch between metabolic states as they proceed from a naïve cell to a memory cell. IL-2
signaling activates mTOR, and since mTOR induces the upregulation of glycolysis, this
is likely the mechanism through which IL-2 drives glycolysis (Ray et al., 2015). The
mechanism through which IL-15 drives oxidative phosphorylation is less clear. The
studies presented here provide one piece of that mechanism. Through the methylation of
the MCJ gene, IL-15 can increase mitochondrial metabolism and oxidative
phosphorylation. This can lead to increased carbon flow through the TCA cycle to
support increased ETC activity, which provides a partial explanation for the observed
utilization of fatty acids to support oxygen consumption seen in IL-15-cultured T cells
(O'Sullivan et al., 2014). The regulation of MCJ expression by IL-15 signaling provides
an example for an understudied method through which metabolism can be regulated in T
cells. Mitochondrial metabolism can be controlled by changing the expression level of
ETC regulators. DNA methylation, specifically of genes related to metabolic pathways, is
another understudied but important avenue of investigation that could be very insightful
in the context of T cell metabolism. As such, IL-15 may promote regulation of several
genes through epigenetic programming.
4.2.3 Linkage of glycolysis, proliferation, and cell death
One gap in knowledge this dissertation aimed to address was a mechanistic
explanation for the high degree of sensitivity to death seen in rapidly proliferating T cells
(Green et al., 2003; Snow et al., 2010). Glycolysis has now been tied to an increase in
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caspase-3 activity that is seen in proliferating T cells, which enhances their susceptibility
to cell death.
Glycolysis is a metabolic state common to many proliferating cells, and the
upregulation of caspase-3 activity may also be common in other cell types. In fact,
intestinal epithelial cells, which renew every 4-5 days, have been shown to become
glycolytic as they migrate from the crypt to the tip of the villus (Yang et al., 2016). These
cells then undergo apoptosis and are replaced by newer cells. This apoptosis coincides
with an increase in caspase-3 activity (Bullen et al., 2006; Grossmann et al., 1998;
Gunther et al., 2013). It is possible that glycolysis is directly linked to the caspase-3
activity seen in these cells.
This linkage of glycolysis to proliferation and death may also be relevant in
cancer cells, which are highly glycolytic (Warburg, 1956). Glycolysis has even been a
recent target of new cancer therapies (Ganapathy-Kanniappan and Geschwind, 2013;
Sheng and Tang, 2016). Increased glycolysis could drive caspase-3 activity in cancer
cells as they proliferate, similar to an effector T cell. Unlike effector T cells however,
cancer cells survive for long periods of time, something that can be partially attributed to
ROS generated at the ETC (Sabharwal and Schumacker, 2014). It is possible that these
ROS induce the inactivation of caspase-3, despite high levels of glycolysis, reducing the
likelihood that a tumor cell will die from caspase-3-induced apoptosis. The link between
glycolysis and cell death in cancer cells would be valuable to study and might lead to new
therapeutic strategies.
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4.2.4 Posttranslational modifications as a way to regulate caspase activity
Caspases are not only important for cell death, but also proliferation, cytokine
maturation, B cell cycling, and cell maturation and differentiation (Lamkanfi et al., 2007;
Misra et al., 2007). Caspases are zymogens and their activity is typically controlled
through the cleavage of the pro-caspase into an active enzyme. The identification of the
posttranslational regulation of caspase activity has been a significant advance to the
understanding of caspase biology. Redox-dependent posttranslational modifications such
as S-nitrosylation and glutathionylation are important modifications for caspases because
they target the cysteine residues of proteins, such as the active site cysteine on caspases
(Huang et al., 2008b; Mitchell and Marletta, 2005b). While ROS play a role in inducing
these modifications in T cells, it is not clear which enzymes are responsible for mediating
them. Further studies will elucidate the mechanisms of S-nitrosylation and
glutathionylation in T cells and provide new ways to modulate caspase activity through
the inhibition or activation of the modifying enzymes.
4.3 Future Directions
The work presented in this dissertation successfully addressed the initial aims of
the study. While a novel connection between glycolysis, proliferation, and death in T
cells has been identified, more questions can be asked to better understand this important
connection. Outlined below are several areas of study that have been opened by this
work.
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4.3.1 Metabolic state, in vivo proliferation, and sensitivity to cell death of T cell
subsets ex vivo
The studies in Chapters 2 and 3 are mostly performed in vitro, though it is
important to determine if these results can be corroborated in vivo. The results from the
flu infection experiment presented in Chapter 2 show that T cells activated by antigen in
vivo do display an increase in caspase-3 activity as they proliferate. It would be
interesting to study the connection between glycolysis, proliferation, and caspase-3
activity in T cells that are proliferating homeostatically in naïve mice. The T cell subsets
of interest include γδ T cells, NKT cells, and Tregs, all of which homeostatically
proliferate more rapidly than most other T cells.
Using flow cytometry, it is possible to study this connection in vivo.
Bromodeoxyuridine (BrdU), which incorporates into DNA during DNA synthesis, can be
used to measure proliferation of cells in vivo. Glucose uptake would be used as a proxy
for glycolysis, and can be measured with a fluorescent version of 2-deoxyglucose called
2-NBDG, which has been used in the past to measure glucose uptake in vivo (Chen et al.,
2013). These probes, combined with anti-active caspase-3, can be used to determine the
level of caspase-3 activity and glucose uptake of the most proliferative T cell subsets by
ex vivo flow cytometric analysis.
4.3.2 Heavy carbon labeling and metabolite tracing
Extracellular acidification and oxygen consumption rates are simple readouts for
complex metabolic processes. Glycolysis contributes carbons to many different anabolic
pathways in the cell. Oxidative phosphorylation is the culmination of any pathway that
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might generate NADH. To truly study the metabolism of a cell, more in depth analysis
than extracellular acidification and oxygen consumption rates are needed.
IL-2 and IL-15 induce dramatic changes in T cell metabolism, but the full picture
of the metabolites used and generated in the cells is still unknown. Using mass
spectrometry, it is possible to identify hundreds of metabolites present within a cell. The
next step in the study of the metabolic differences between T cells cultured in IL-2 or IL15 is to use a mass spectrometry approach to determine the differences in individual or
classes of metabolites present. However, this approach returns a snapshot of what was
present in the cell at the time of the analysis. Using carbon-13 (13C)-labeled reagents,
such as glutamine or glucose, it is possible to identify the metabolites generated from
those initial fuel sources. This technique, called heavy isotope labeling or metabolite
tracing, allows for the identification of the pathways a cell will use to catabolize the
labeled metabolite, and then see where the cell incorporates those carbons. These
metabolomic studies are in progress and are summarized in Appendix A.
4.3.3 Mechanism of caspase-3 association with lipid rafts
The identification of caspase-3 in lipid rafts was a reasonable expectation
considering there was no difference in upstream caspase activity between glycolytic and
non-glycolytic T cells. In glycolytic cells, proximity-induced autoactivation of caspase-3
is more likely to occur when the caspase is clustered in a confined region, such as a lipid
raft in the cellular membrane. This raises the question of how caspase-3 initially gets to
the membrane. Proteins that lack a transmembrane domain often become associated with
membranes through a lipid-based posttranslational modification called acylation.
Acylation includes modifications with many lipids or fatty acids including palmitate,
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which can be generated by glycolytic cells (Levental et al., 2010; Lunt and Vander
Heiden, 2011).
Preliminary studies indicate that palmitate is a major fatty acid produced by
glycolytic T cells (Fig. A.7). Future studies could investigate the hypothesis that caspase3 is acylated in glycolytic T cells and to a lesser extent in non-glycolytic T cells.
Acylation of caspase-3 can be detected using a biotin switch technique in which the acyl
groups on proteins are replaced with a biotin-conjugated compound, and then precipitated
and probed for caspase-3. Expression levels of enzymes involved in acylation could also
be measured, along with activity levels. If caspase-3 is acylated in glycolytic T cells, then
blocking fatty acid production and/or acylation should result in a decrease in caspase-3
localization to lipid rafts and activation. These studies would provide further insight into
acylation as a method of regulating caspase activity and would link acylation to the
metabolic state of T cells.
4.3.4 Mechanism by which MCJ promotes caspase-3 activity
Glycolysis and MCJ expression are both linked to activation of caspase-3. While
glycolysis is known to lead to the localization of caspase-3 in lipid rafts to induce
activation, it is not known how MCJ drives caspase-3 activity. It is possible that MCJ acts
to prevent the S-nitrosylation and glutathionylation of caspase-3 by reducing complex I
activity and subsequently mitochondrial ROS generation. If this is true, then the MCJdeficient cells should have increased mitochondrial ROS as well as S-nitrosylation and/or
glutathionylation of caspase-3. Reducing mitochondrial ROS with mitoQ could then
increase caspase activity. It is also possible that the expression of MCJ increases
glycolysis, which would promote caspase-3 activity through the glycolysis-related
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mechanisms. In this case, the MCJ-deficient cells should have less active caspase-3
present in lipid rafts. Discovering the mechanism of MCJ induction of caspase-3 activity
will provide evidence for another non-caspase-mediated method of caspase activation and
a better appreciation for the complexity of caspase regulation in T cells.
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APPENDIX A: METABOLOMICS AND METABOLITE TRACING IN T CELLS
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A.1 Introduction
Immunometabolism is now recognized as an important factor in understanding the
function of immune cells. As was outlined in Chapter 1, different metabolic pathways are
important at different points in time during an immune response. This has led to a greater
desire for more detail of the levels of actual metabolites in immune cells at various points
in an immune response, and for the kinetics and fate of whether these metabolites go in a
pathway. Thus, as part of our studies of the metabolism of T cells cultivated in IL-2
versus IL-15, we conducted metabolomics studies in these two T cell populations.
We have shown that IL-2-cultured effector T cells utilize glucose and reduce
OXPHOS, whereas IL-15-cultured memory-like T cells manifest the opposite metabolic
profile. We thus aimed to better understand how these two T cell populations utilize fuel
sources. We initially used mass spectrometry to measure the static differences in
metabolites produced in IL-2-cultured versus IL-15-cultured T cells. We then performed
kinetic studies using 13C-glucose or 13C-glutamine labeling to follow the kinetics and path
of carbons from these two fuel sources.
A.2 Results and Discussion
We measured 184 metabolites by mass spectrometry (Table A.1, Fig. A.1). As IL15-cultured cells are smaller than the IL-2-cultured cells (and the mass spectrometry was
performed on an equivalent number of cells), so we reasoned that any metabolites that
appeared in a higher amount in the IL-15 cells compared to IL-2, were likely to be
significant for IL-15-driven metabolism. Two metabolites were identified: L-glutamine
and D-glucose. For most of the metabolites, the IL-2-cultured CD8+ T cells contained the
greatest amount of these metabolites.
169

Given the known higher level of OXPHOS in IL-15-cultured T cells, we
hypothesized that the high level of glutamine in the IL-15-cultured T cells was a result of
the need to fuel the TCA cycle with glutamine. However, the high level of glucose in the
IL-15-cultured T cells was unexpected. This static metabolic picture suggested that IL-15
T cells either took up glucose but did not use it, hence its accumulation, or that it might
utilize glucose for pathways other than glycolysis to lactate production (which is low in
IL-15 T cells). To better track the kinetics and fate of glucose and glutamine carbons we
used 13C-glucose and 13C-glutamine labeling. We added the 13C-glucose or 13C-glutamine
to glucose- or glutamine-free media and cultured the cells for 6 and 24 hours (for the IL15-cultured CD4+ T cells, only the 6-hour time-point was measurable). Key metabolites
in the glycolysis pathway and the TCA cycle, as well as some amino acids, were
measured for the presence of 13C (e.g. M+0 representing no labeled carbons and M+3
representing 3 labeled carbons), indicating the use of either glucose or glutamine to make
those metabolites.
In the 13C-glutamine tracing experiments, the presence of 13C in the metabolites of
the TCA cycle indicated that glutamine is used by both IL-2-cultured and IL-15-cultured
T cells to generate glutamate, and subsequently fuel the TCA cycle (Fig. A.2), which is a
known use of glutamine in cells. There was a moderate amount of labeling in glutathione
and aspartate in both cultures (Fig. A.3). The 13C-glucose tracing experiments revealed
that glucose is catabolized in both the IL-2-cultured cells and the IL-15-cultured cells,
though lactate was produced almost exclusively by the IL-2-cultured cells (Fig. A.4).
Glucose was used to generate metabolites of the TCA cycle in each of the cell cultures
(Fig. A.5), though at a low level. We also found glucose to be used by the IL-2-cultured
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T cells to generate certain amino acids such as alanine and serine, but not by the IL-15cultured T cells. The exception was in cysteine, which was generated from glucose in
each culture (Fig. A.6). Most striking was that when tracking the labeled carbons from
13

C-glucose they appeared to disappear in the IL-15-cultured T cells before entry into the

TCA cycle. Thus, if glucose was not being metabolized to lactate or the TCA cycle in IL15 T cells, it suggested that the carbons were being diverted to another pathway. Due to
the targeted measurements that were made, we were unable to determine if these carbons
entered any pathways that branch off glycolysis, such as the pentose phosphate pathway
or incorporation into lipids. These will be pursued in future studies.
In a separate set of analyses, we were interested in the generation of lipids and
fatty acids in IL-2-cultured and IL-15-cultured T cells, as IL-15-cultured T cells are
known to use fatty acids to fuel the TCA cycle, and IL-2-cultured T cells may use fatty
acids such as palmitate to tether caspase-3 to lipid rafts. We measured fatty acids and
lipids by mass spectrometry in CD4+ and CD8+ T cells cultured in IL-2 or IL-15. We
observed that triacylglycerides (TAG) were produced in similar amounts between IL-2cultured and IL-15-cultured T cells, with the CD8+ T cells producing the most (Fig. A.7).
Palmitate (16:0) and linoleate (18:0) were favored among the medium-chain fatty acids,
with the IL-15-cultured cells favoring linoleate with 2 unsaturated double bonds (18:2)
(Fig. A.6). Palmitate can be used to modify proteins by acylation, which could be used by
glycolytic cells to modify caspase-3 for localization in lipid rafts. Diacylglycerides were
found at a higher level in IL-2-cultured cells compared to IL-15 (Fig. A.8). Of the
glycerophospholipids, phosphatidylcholine was found at a greater amount in the IL-2cultured T cells, while cardiolipin was found at a greater amount in CD8+ T cells,
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compared to CD4+ (Fig. A.9). IL-15-cultured T cells contained a greater amount of
sphingomyelin compared to IL-2 (Fig. A.10). Together, these data suggest a preference
for different lipids between IL-2-cultured T cells and IL-15-cultured T cells. A kinetic
approach to determine the metabolites used to generate those lipids will enable us to
better understand the role of lipid metabolism in effector function and survival in T cells.
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Figure A.1: Heat map of metabolite presences from metabolomics screen
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Figure A.2: TCA cycle intermediates from 13C-glutamine tracing
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Figure A.3: Other metabolites detected from 13C-glutamine tracing

175

Figure A.4: Glycolysis intermediates from 13C-glucose tracing
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Figure A.5: TCA cycle intermediates from 13C-glucose tracing
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Figure A.6: Other metabolites of interest from 13C-glucose tracing
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Figure A.7: Triacylglycerides detected in lipidomics screen
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Figure A.8: Diacylglycerides and MADAGs detected in lipidomics screen
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Figure A.9: Glycerophospholipids detected in metabolomics screen
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Figure A.10: Other lipids detected in lipidomics screen
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Table 1: List of metabolites detected in metabolomics screen
MEDIAN VALUES

CD4
IL-2

CD4
IL-15

CD8
IL-2

CD8
IL-15

p-values
CD4
IL2/IL15

p-values
CD8
IL2/IL15

Compound

Pathway

L-Alanine

Amino acids

7.45E+06

6.69E+06

1.45E+07

5.98E+06

0.072708

0.030676

L-Arginine

Amino acids

2.80E+06

2.66E+06

3.69E+06

2.82E+06

0.407852

0.026131

L-Asparagine

Amino acids

1.99E+06

6.22E+05

2.79E+06

1.32E+06

0.076455

0.042529

L-Aspartate

Amino acids

1.23E+07

5.94E+06

1.56E+07

1.01E+07

0.033673

0.117431

L-Cysteine

Amino acids

3.25E+05

2.20E+05

4.59E+05

2.79E+05

0.305108

0.093564

L-Glutamate

Amino acids

2.93E+07

7.85E+06

6.73E+07

1.22E+07

0.08386

0.021772

L-Glutamine

Amino acids

1.33E+06

2.53E+06

1.52E+06

4.52E+06

0.015861

0.014339

Glycine

Amino acids

8.70E+06

7.56E+06

9.59E+06

7.53E+06

0.089711

0.029004

L-Histidine

Amino acids

2.64E+05

2.96E+05

3.73E+05

3.03E+05

0.430782

0.030591

L-Isoleucine

Amino acids

1.96E+06

1.89E+06

2.84E+06

2.21E+06

0.820098

0.076515

L-Leucine

Amino acids

8.99E+06

1.20E+07

1.84E+07

1.16E+07

0.312082

0.023488

L-Lysine

Amino acids

3.81E+05

4.97E+05

6.88E+05

4.86E+05

0.029648

0.024459

L-Methionine

Amino acids

5.32E+05

9.24E+05

1.01E+06

9.21E+05

0.010751

0.154122

L-Phenylalanine

Amino acids

1.07E+06

1.38E+06

2.16E+06

1.20E+06

0.049946

0.000949

L-Proline

Amino acids

1.05E+08

1.46E+07

2.25E+08

2.27E+07

0.083794

0.023635

L-Serine

Amino acids

5.89E+05

2.93E+05

1.16E+06

4.66E+05

0.015903

0.027317

L-Threonine

Amino acids

6.19E+05

5.86E+05

9.26E+05

5.72E+05

0.534458

0.046158

L-Tryptophan

Amino acids

3.23E+05

4.67E+05

6.94E+05

4.12E+05

0.268589

0.280053

L-Tyrosine

Amino acids

7.43E+05

1.02E+06

1.49E+06

8.94E+05

0.076287

0.060215

L-Valine

Amino acids

1.43E+07

1.00E+07

4.22E+07

1.00E+07

0.331358

0.017063

L-Cystine

Amino acids

2.00E+05

1.67E+05

1.15E+05

1.61E+05

0.552432

0.037842

Kynurenine

Amino acids

1.10E+04

1.27E+04

1.43E+04

9.16E+03

0.702875

0.658727

ATP

Nucleotides

0.00E+00

0.00E+00

2.76E+04

0.00E+00

0.42265

0.018577

ADP

Nucleotides

9.40E+05

3.45E+05

1.37E+06

4.42E+05

0.097317

0.031215

AMP

Nucleotides

1.02E+07

6.63E+06

3.77E+07

7.39E+06

0.282606

0.021778

GMP

Nucleotides

4.43E+05

2.06E+05

1.39E+06

2.69E+05

0.183657

0.003058

IMP

Nucleotides

7.44E+04

0.00E+00

1.05E+05

0.00E+00

0.100605

0.015766

CMP

Nucleotides

2.57E+05

7.07E+04

6.34E+05

1.08E+05

0.118015

0.018407

Hypoxanthine

Nucleotides

1.00E+06

7.91E+05

1.03E+06

6.80E+05

0.174395

0.161528

Adenine

Nucleotides

5.26E+05

3.93E+05

1.30E+06

4.68E+05

0.308113

0.025403

Xanthine

Nucleotides

2.45E+04

0.00E+00

7.05E+04

0.00E+00

0.107928

0.012801

Guanine

Nucleotides

1.29E+05

1.18E+05

2.10E+05

1.01E+05

0.464383

0.044314
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Allantoate

Nucleotides

4.13E+04

2.98E+04

2.04E+04

2.14E+04

0.620706

0.944156

(S)(+)-Allantoin

Nucleotides

1.09E+04

1.56E+04

2.48E+04

1.55E+04

0.460547

0.213469

5-Hydroxyisourate

Nucleotides

5.20E+04

4.28E+04

7.41E+04

1.42E+05

0.396269

0.085156

5--Phosphoribosyl-Nformylglycinamide

Nucleotides

2.44E+04

0.00E+00

3.15E+04

0.00E+00

0.022102

0.083677

5-Phosphoribosylamine

Nucleotides

4.96E+03

0.00E+00

1.59E+04

0.00E+00

0.244222

0.058107

UMP

Nucleotides

4.30E+05

2.24E+05

1.47E+06

2.61E+05

0.219222

0.016368

Cytidine

Nucleotides

4.19E+04

3.36E+04

1.65E+05

9.57E+03

0.505794

0.062492

2--3--Cyclic CMP

Nucleotides

0.00E+00

9.87E+03

0.00E+00

1.59E+04

0.072785

0.264603

3-Ureidopropionate

Nucleotides

1.99E+06

6.22E+05

2.79E+06

1.32E+06

0.076455

0.042529

5-6-Dihydrothymine

Nucleotides

7.91E+05

7.94E+05

1.20E+06

7.31E+05

0.710849

0.002913

Thymine

Nucleotides

1.16E+05

9.48E+04

9.78E+04

8.36E+04

0.052002

0.18994

Thymidine

Nucleotides

1.47E+04

7.15E+03

8.13E+03

7.59E+03

0.161941

0.799713

NAD+

Nucleotides

2.66E+05

7.21E+04

5.35E+05

6.54E+04

0.052271

0.011496

NADH

Nucleotides

5.31E+04

0.00E+00

1.29E+05

8.96E+03

0.135876

0.008261

NADP+

Nucleotides

1.61E+06

1.44E+06

1.14E+06

1.64E+06

0.838282

0.163485

NADPH

Nucleotides

2.50E+05

2.52E+05

1.79E+05

2.59E+05

0.979524

0.076451

Pyridoxal

Nucleotides

1.44E+05

1.47E+05

1.06E+05

1.24E+05

0.361404

0.176493

4-Pyridoxate

Nucleotides

2.53E+04

6.03E+03

2.10E+04

4.61E+03

0.028138

0.028277

Pyridoxamine phosphate

Nucleotides

0.00E+00

0.00E+00

2.39E+04

2.66E+04

0.42265

0.627359

Nicotinamide

Nucleotides

2.81E+06

1.92E+06

4.83E+06

2.76E+06

0.141886

0.014861

ADP-D-ribose

Nucleotides

6.09E+03

4.02E+03

2.89E+04

1.21E+04

0.011553

0.292165

Flavin

Nucleotides

8.68E+05

5.70E+05

5.12E+05

5.10E+05

0.003935

0.164477

Adenosine

Nucleotides

1.73E+05

6.98E+04

1.63E+05

1.05E+05

0.117165

0.336763

Guanosine

Nucleotides

4.03E+05

6.47E+05

4.59E+05

5.76E+05

0.054387

0.027987

Inosine

Nucleotides

7.50E+04

3.46E+04

1.01E+05

7.67E+04

0.161178

0.320498

D-Glucose

Glycolysis

1.93E+05

4.57E+05

1.12E+05

2.50E+05

0.01678

0.203444

D-Hexose 6-phosphate

Glycolysis

1.59E+06

1.34E+06

1.87E+06

6.43E+05

0.219015

0.09549

D-Glyceraldehyde 3phosphate

Glycolysis

4.43E+05

1.51E+05

9.01E+05

1.86E+05

0.08294

0.011906

2-3-Bisphosphoglycerate

Glycolysis

1.77E+04

1.43E+04

1.60E+04

1.11E+04

0.558055

0.589865

2/3-Phospho-D-glycerate

Glycolysis

5.07E+05

1.38E+05

7.75E+05

2.35E+05

0.02117

0.042108

Phosphoenolpyruvate

Glycolysis

3.42E+04

5.42E+03

4.30E+04

1.52E+04

0.057914

0.021401

Pyruvate

Glycolysis

3.74E+06

3.33E+06

3.90E+06

2.90E+06

0.167724

0.009775

Lactate

Glycolysis

1.47E+07

7.11E+06

1.52E+07

6.24E+06

0.098765

0.015363

cis-Aconitate

Carboxylic acid

2.94E+05

3.96E+04

5.09E+05

1.05E+05

0.137392

0.013973

Citrate

Carboxylic acid

8.14E+06

1.13E+06

1.37E+07

2.49E+06

0.058377

0.00301

2-Oxoglutarate

Carboxylic acid

4.69E+05

2.14E+05

1.81E+06

1.99E+05

0.064485

0.015398

2-Oxoglutaramate

Carboxylic acid

6.92E+05

7.12E+05

7.41E+05

7.32E+05

0.883276

0.631274

Succinate

Carboxylic acid

9.82E+05

5.84E+05

2.32E+06

5.92E+05

0.187048

0.031421
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Fumarate

Carboxylic acid

1.86E+06

3.12E+05

4.27E+06

5.13E+05

0.056742

0.000454

Oxaloacetate

Carboxylic acid

9.10E+05

7.83E+05

8.90E+05

9.94E+05

0.125545

0.291215

5-Aminolevulinate

Carboxylic acid

4.00E+05

1.94E+05

5.26E+05

1.78E+05

0.130164

0.011687

D-Glucono-1-5-lactone 6phosphate

3.26E+04

3.79E+04

3.79E+04

3.33E+04

0.461316

0.32376

2.06E+04

1.98E+04

3.30E+04

1.54E+04

0.673939

0.073221

1.25E+05

1.28E+05

1.24E+05

1.33E+05

0.222303

0.289537

Sedoheptulose 1phosphate
alpha-D-Ribose 1phosphate

Pentose Phosphate
Pathway
Pentose Phosphate
Pathway
Pentose Phosphate
Pathway
Pentose Phosphate
Pathway
Pentose Phosphate
Pathway

2.16E+05

2.59E+06

3.19E+05

9.47E+04

0.085882

0.014742

9.70E+05

2.80E+05

8.98E+05

3.79E+05

0.007873

6.36E-05

Glutathione

GSH homeostasis

3.27E+07

1.62E+07

5.34E+07

1.84E+07

0.091319

0.01837

Glutathione disulfide

GSH homeostasis

0.00E+00

1.24E+04

0.00E+00

0.00E+00

0.132214

#DIV/0!

5-Oxoproline

GSH homeostasis

8.53E+06

4.70E+06

1.50E+07

5.60E+06

0.131362

0.044157

gamma-L-Glutamyl-Lcysteine

GSH homeostasis

1.55E+04

6.51E+04

3.11E+04

1.46E+04

0.003797

0.401075

Dehydroascorbate

GSH homeostasis

9.09E+04

1.04E+04

1.91E+05

7.96E+03

0.056599

0.033917

Ascorbate

GSH homeostasis

8.22E+05

8.01E+05

8.09E+05

8.00E+05

0.746642

0.450265

2.50E+04

0.00E+00

7.69E+04

0.00E+00

0.14869

0.039012

8.58E+04

6.60E+03

2.14E+05

6.07E+03

0.066429

0.009586

6.19E+05

5.86E+05

9.26E+05

5.72E+05

0.534458

0.046158

1.28E+05

5.67E+04

2.64E+05

2.88E+04

0.009206

0.01371

1.09E+05

4.26E+04

3.39E+05

2.44E+04

0.186883

0.050689

1.17E+05

1.43E+05

1.31E+05

1.43E+05

0.017432

0.25162

3.62E+03

0.00E+00

3.24E+03

0.00E+00

0.987044

0.598163

8.86E+05

8.08E+05

6.49E+05

6.15E+05

0.161273

0.345234

0.00E+00

0.00E+00

8.72E+04

1.54E+04

0.42265

0.002364

1.28E+05

6.14E+04

8.44E+04

4.77E+04

0.779059

0.064859

4.51E+04

3.79E+04

2.88E+04

3.06E+04

0.742251

0.658611

2.91E+04

0.00E+00

1.25E+05

0.00E+00

0.134058

0.020551

6.98E+04

1.53E+04

2.11E+05

7.75E+03

0.297307

0.0712

1.73E+06

6.20E+05

2.54E+06

1.05E+06

0.00361

0.099784

6-Phospho-D-gluconate
D-Erythrose 4-phosphate

S-Adenosyl-Lhomocysteine
S-Adenosyl-L-methionine

L-Homoserine

L-Homocysteine

D-O-Phosphoserine

3-Phosphonopyruvate

Cystathionine

N-N-Dimethylglycine
5,10Methenyltetrahydrofolate
Ornithine
L-Citrulline
N-(L-Arginino)succinate
Urate
Spermidine

Serine biosynthesis
and one-carbon
metabolism
Serine biosynthesis
and one-carbon
metabolism
Serine biosynthesis
and one-carbon
metabolism
Serine biosynthesis
and one-carbon
metabolism
Serine biosynthesis
and one-carbon
metabolism
Serine biosynthesis
and one-carbon
metabolism
Serine biosynthesis
and one-carbon
metabolism
Serine biosynthesis
and one-carbon
metabolism
Serine biosynthesis
and one-carbon
metabolism
urea cycle and
polyamines
urea cycle and
polyamines
urea cycle and
polyamines
urea cycle and
polyamines
urea cycle and
polyamines
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Spermine
Putrescine
Atherospermidine

urea cycle and
polyamines
urea cycle and
polyamines
urea cycle and
polyamines

2.86E+05

1.35E+05

4.59E+05

3.06E+05

0.076123

0.491903

8.72E+05

3.32E+05

1.41E+06

4.60E+05

0.078532

0.018562

0.00E+00

0.00E+00

0.00E+00

1.05E+04

0.42265

0.491965

N-Acetylneuraminate

Aminosugars

0.00E+00

0.00E+00

9.06E+04

0.00E+00

#DIV/0!

0.007919

CMP-Nacetylneuraminate

Aminosugars

3.53E+04

0.00E+00

2.46E+05

0.00E+00

0.188045

0.00126

N-Glycoloyl-neuraminate

Aminosugars

3.44E+04

0.00E+00

3.82E+04

1.92E+04

0.00204

0.065713

alpha-D-Glucosamine 1phosphate

Aminosugars

2.07E+04

4.39E+03

6.04E+04

0.00E+00

0.04835

0.040595

D-Glucosamine

Aminosugars

2.70E+04

2.66E+04

2.77E+04

2.18E+04

0.139908

0.213033

L-Arabinose

Aminosugars

2.67E+05

2.70E+05

2.56E+05

2.54E+05

0.917799

0.136842

Aminosugars

9.70E+05

2.80E+05

8.98E+05

3.79E+05

0.007873

6.36E-05

1.79E+04

1.20E+04

1.74E+04

8.83E+03

0.907852

0.179614

6.98E+04

6.75E+04

7.07E+04

5.40E+04

0.974661

0.2359

1.45E+04

1.96E+04

7.41E+04

4.77E+04

0.95637

0.014488

1.31E+06

1.36E+06

2.82E+06

1.54E+06

0.800275

0.064045

1.34E+07

9.68E+06

1.25E+07

5.81E+06

0.340564

0.066637

4.18E+05

4.55E+05

5.47E+05

3.90E+05

0.217779

0.003205

4.60E+05

4.54E+05

4.53E+05

4.61E+05

0.517909

0.87405

1.62E+05

1.85E+05

1.66E+05

1.71E+05

0.002336

0.750584

0.00E+00

3.56E+03

0.00E+00

7.03E+03

0.313867

0.750099

2.80E+05

6.95E+04

6.33E+05

6.46E+04

0.076905

0.006675

5.79E+06

1.29E+06

9.90E+06

2.58E+06

0.081736

0.013079

1.43E+07

1.00E+07

4.22E+07

1.00E+07

0.331358

0.017063

5.98E+05

7.62E+05

1.39E+06

8.30E+05

0.23695

0.010578

1.34E+04

3.81E+04

7.29E+04

3.03E+04

0.719887

0.015928

beta-L-Arabinose 1phosphate
gamma-Glutamyl-gammaaminobutyrate

L-1-Pyrroline-3-hydroxy5-carboxylate
Aminofructose 6phosphate

Arginine and proline
metabolism
Arginine and proline
metabolism
Arginine and proline
metabolism
Arginine and proline
metabolism
Arginine and proline
metabolism
Arginine and proline
metabolism
Arginine and proline
metabolism
Arginine and proline
metabolism
Arginine and proline
metabolism
Arginine and proline
metabolism
Arginine and proline
metabolism
Arginine and proline
metabolism
Arginine and proline
metabolism
Arginine and proline
metabolism

L-Allothreonine

Inositol

6.19E+05

5.86E+05

9.26E+05

5.72E+05

0.534458

0.046158

Ectoine

Inositol

3.39E+05

2.90E+05

2.68E+05

2.44E+05

0.024611

0.219024

5.68E+04

4.95E+04

1.10E+05

5.85E+04

0.415628

0.131984

5.98E+05

5.63E+05

5.12E+05

4.66E+05

0.146306

0.19649

6.59E+03

3.29E+03

5.41E+03

7.40E+03

0.05854

0.779965

N-Succinyl-L-glutamate
N-Succinyl-L-glutamate 5semialdehyde
Phosphocreatine
Creatine
Creatinine
4-Acetamidobutanoate
N-Acetylornithine
N-Succinyl-L-citrulline
Guanidinoacetate
trans-4-Hydroxy-L-proline
5-Aminopentanoate

Uracil
5-6-Dihydrouracil
Pantetheine

Panthothenate
metabolism
Panthothenate
metabolism
Panthothenate
metabolism

L-Carnitine

Carnitines

2.78E+06

2.72E+06

3.47E+06

2.12E+06

0.935771

0.024973

Propanoylcarnitine

Carnitines

1.05E+06

5.97E+05

5.36E+05

3.02E+05

0.171996

0.047566

Butanoylcarnitine

Carnitines

3.00E+05

8.00E+04

4.97E+05

1.12E+05

0.142359

0.031754
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Catechol
Catecholamine
Serotonin
Catechin
Taurine
Hypotaurine
sn-Glycerol 3-phosphate
Ethanolamine phosphate
N-Methylethanolamine
phosphate
sn-glycero-3Phosphoethanolamine
Diacylglycerylhomoserine
CDP-choline

Stimulating/Exogenous
compounds
Stimulating/Exogenous
compounds
Stimulating/Exogenous
compounds
Stimulating/Exogenous
compounds
Stimulating/Exogenous
compounds
Stimulating/Exogenous
compounds
Glycerophospholipid
biosynthesis
Glycerophospholipid
biosynthesis
Glycerophospholipid
biosynthesis
Glycerophospholipid
biosynthesis
Glycerophospholipid
biosynthesis
Glycerophospholipid
biosynthesis

4.17E+04

3.78E+04

3.46E+04

4.62E+04

0.969784

0.393787

5.45E+04

6.17E+04

6.11E+04

5.59E+04

0.077114

0.398904

6.40E+04

9.97E+04

0.00E+00

3.08E+04

0.612467

0.115503

8.36E+03

0.00E+00

9.78E+03

7.68E+03

0.010999

0.9923

1.62E+07

2.03E+07

2.26E+07

1.80E+07

0.110122

0.195495

6.51E+05

3.26E+05

8.12E+05

3.52E+05

0.156431

0.029762

2.11E+05

5.09E+04

3.19E+05

5.45E+04

0.019641

0.006811

0.00E+00

9.27E+04

0.00E+00

1.36E+05

0.06536

0.032273

5.72E+05

5.39E+05

6.60E+05

5.46E+05

0.188516

0.202876

4.81E+05

3.71E+05

8.26E+04

2.75E+05

0.701032

0.060936

3.06E+04

4.67E+04

2.48E+04

1.65E+04

0.592031

0.720078

0.00E+00

0.00E+00

1.61E+04

0.00E+00

0.42265

0.043266

Butanoic acid

Saturated Fatty acids

1.22E+05

1.77E+05

1.26E+05

1.14E+05

0.264483

0.949846

Pentanoate

Saturated Fatty acids

1.55E+06

5.96E+04

1.08E+06

1.59E+06

0.50837

0.257631

Hexanoic acid

Saturated Fatty acids

1.02E+05

1.20E+05

9.54E+04

1.07E+05

0.177557

0.747281

Octanoic acid

Saturated Fatty acids

1.39E+04

4.06E+04

2.20E+04

1.91E+04

0.185764

0.895049

2.90E+04

3.55E+04

2.08E+04

2.88E+04

0.353093

0.670345

5.36E+04

1.27E+05

6.19E+04

4.45E+04

0.00266

0.804765

Lipids

1.42E+05

1.29E+05

9.73E+04

1.13E+05

0.899956

0.822927

Lipids

5.55E+04

2.54E+04

2.20E+04

1.66E+04

0.10714

0.628056

Indole

Other

6.60E+04

6.03E+04

6.03E+04

5.40E+04

0.583955

0.040829

Acetyl phosphate

Other

8.38E+04

1.41E+05

1.20E+05

9.99E+04

0.073213

0.186379

Triacanthine

Other

7.28E+06

2.93E+06

7.21E+06

1.98E+06

0.168637

0.024111

1-Hydroxy-2aminoethylphosphonate

Other

1.27E+04

1.69E+05

5.44E+03

2.37E+05

0.022415

0.002269

N5-Methyl-L-glutamine

Other

6.39E+04

6.99E+04

5.77E+04

6.16E+04

0.772619

0.595913

2-Methyleneglutarate

Other

2.65E+04

1.76E+04

5.43E+04

2.85E+04

0.572722

0.03195

Other

0.00E+00

0.00E+00

5.50E+03

0.00E+00

0.42265

0.038041

Other

1.39E+06

2.15E+06

1.74E+06

1.83E+06

0.054295

0.392468

6-Aminohexanoate

Other

8.99E+06

1.20E+07

1.84E+07

1.16E+07

0.312082

0.023488

Leucocyanidin

Other

5.37E+04

6.39E+04

6.81E+04

2.62E+04

0.867122

0.139762

Methylenediurea

Other

1.17E+05

8.37E+04

1.23E+05

4.83E+04

0.284546

0.117682

beta-Butoxyethyl
nicotinate

Other

8.28E+04

1.19E+05

1.32E+05

9.54E+04

0.126536

0.324006

3-Oxalomalate

Other

6.46E+04

7.39E+04

6.95E+04

1.55E+05

0.087566

0.067878

Octadecatrienoic acid
Docosahexaenoic acid
alhpatocopheronolactone
hydroxy-dodecanedioic
acid

6Pyruvoyltetrahydropterin
6-Lactoyl-5-6-7-8tetrahydropterin

Poly-unsaturated Fatty
Acids
Poly-unsaturated Fatty
Acids

187

Cys-Gly

Other

2.91E+05

1.53E+05

5.14E+05

1.67E+05

0.106137

0.022454

2-Deoxy-alpha-Dglucoside

Other

2.40E+06

7.26E+05

3.26E+06

9.40E+05

0.064777

0.014643

cis-p-Coumarate

Other

9.97E+04

1.46E+05

2.42E+05

1.17E+05

0.072714

0.004236

L-Methionine S-oxide

Other

3.32E+03

1.43E+04

3.57E+04

3.92E+04

0.027192

0.101541

N-Acyl-Dmannosaminolactone

Other

9.38E+04

1.13E+05

4.62E+04

4.20E+04

0.846898

0.24813

N6-Methyl-L-lysine

Other

1.16E+05

1.54E+05

2.10E+05

2.44E+05

0.173233

0.862469

Muramic acid

Other

1.84E+05

8.72E+04

2.60E+05

7.72E+04

0.095256

0.076655

Dethiobiotin

Other

2.34E+05

1.18E+05

4.81E+05

1.07E+05

0.024221

0.01212

L-2-Aminoadipate

Other

3.75E+05

1.94E+05

2.59E+05

1.83E+05

0.054784

0.170825

Threonate

Other

4.31E+04

7.98E+04

5.07E+04

2.85E+04

0.054181

0.216125

Tripeptide

Other

1.51E+06

3.47E+05

1.05E+06

2.43E+05

0.006907

0.013881

Maleamate

Other

5.30E+05

2.81E+05

8.21E+05

4.93E+05

0.027707

0.101479

gamma-Glutamyl-Semethylselenocysteine

Other

1.83E+04

4.13E+05

7.92E+04

1.80E+04

0.109108

0.040747

Diallyl sulfide

Other

1.50E+05

5.64E+04

1.65E+05

6.24E+04

0.064123

0.012485

Shikimate 3-phosphate

Other

5.49E+03

0.00E+00

3.67E+04

0.00E+00

0.813192

0.007178

D-glucono-1,5-lactone

Other

1.28E+05

1.53E+05

9.30E+04

9.80E+04

0.437909

0.994762

2-Dehydro-3-deoxy-Dglucarate

Other

3.55E+04

1.81E+03

7.89E+04

5.77E+03

0.057428

0.001181

Sodium glucuronate

Other

3.76E+03

0.00E+00

1.11E+04

0.00E+00

0.138957

0.03339

Poly-gamma-D-glutamate

Other

5.98E+05

7.62E+05

1.39E+06

8.30E+05

0.23695

0.010578

Dihydroflavonol

Other

1.05E+04

0.00E+00

4.25E+04

0.00E+00

0.045372

0.04956
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